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ABSTRACT

NEUROPSYCHOLOGICAL ASSESSMENT OF WORKING MEMORY, PROCESSING
SPEED, AND COGNITIVE FATIGUE AMONG INDIVIDUALS WITH SICKLE CELL
DISEASE: A BIOPSYCHOSOCIAL DEVELOPMENTAL PERSPECTIVE

Sickle Cell Disease (SCD) is a chronic disease that continues to impact individuals of
African American, Caribbean, Hispanic, Indian, Mediterranean, and Middle Eastern descent

(Swain, Mitchell, & Powers, 2006). Children and adolescents with SCD are faced with numerous
medical problems, which can arise unexpectedly throughout their lives, including an increased
risk for cerebrovascular accidents (CVAs). Recent literature suggests that children with SCD and
no detectable neurological insults may be at risk for neuropsychological difficulties. Further,
there is evidence of possible cumulative effects of the disease on cognitive functioning with age.
Despite evidence that specific measures of cognitive functioning are more sensitive in detecting
cognitive deficits, there remains a dearth of literature on specific neuropsychological domains
among children and adolescents with SCD and no evidence of CVA as well as literature
examining the theory of an age-related decrement.
Participants were 14 children and adolescents with SCD and no documented history of
stroke and 19 unmatched healthy controls ages 9 through 22 years old. The results of the current
study reveal mixed findings. Children with SCD demonstrated significantly lower scores on the
WRAML-2 Working Memory Index and the WISC-IVIWAIS-111Processing Speed Index
compared to control group. An age-related decrement was not found with regard to working
memory and processing speed. Moreover, working memory was positively related to age,
indicating that working memory scores potentially improve with age. Finally, on an objective

method for measuring cognitive fatigue on the CPT-11, differences between groups did not reach
statistical significance; however, there was an indication that the SCD group slowed in the
second half, as expected. The findings of the SCD group provide important implications for
future research and practice.
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CHAPTER 1
Introduction
Sickle cell disease (SCD) is currently the most common group of inherited
diseases among African American children, with approximately 1 in every 500 African
Americans being born with SCD (Armstrong, 2006). Further, about 1 in 12 African
Americans and about 1 in 100 Hispanic Americans are carriers of the sickle cell trait
(Gustafson, Bonner, Hardy, &Thompson, 2006; Ris & Grueneich, 2000). While
individuals of Afiican and Caribbean descent comprise the greatest percentage of SCD
cases, individuals of Indian, Mediterranean, and Middle Eastern descent are also affected
(Swain, Mitchell, & Powers, 2006). It is estimated that SCD affects over 2 million people
worldwide, with approximately 72,000 of these being Americans (US. Department of
,
Hence, SCD is a public health concern, particularly
Health and Human S e ~ c e s2002).
with young American ethnic minority groups.

Medical Problems during Childhood and Adolescence
Children and adolescents with SCD are faced with numerous medical problems
which can arise unexpectedly throughout their lives. Throughout infancy, babies with
SCD are at risk for acute illnesses and pain crises during the infant stage of development,
colic-like symptoms, and feeding problems (Ris & Grueneich, 2000). These infants are
also at risk for streptococcus pneumonia, although treatments with penicillin are now able

to prevent many of these infections h m occurring. Other risks for infants with SCD
include low birth weight, mild fetal hypoxia, and brain injury (Schatz & Puffer, 2006).
There is significant concern for children with SCD as they remain at risk for
cerebral vascular accidents, commonly known as strokes and infarctions, or even cell
death (Ris & Grueneich, 2000). Approximately 5-10% of children with SCD experience
cerebrovascular accidents, and 11-20% of children with SCD experience silent strokes,
strokes that are not detectable by radiographic techniques (Gustafson et al., 2006).
Individuals who are homozygous for hemoglobin S (HbSS) are primarily affected by
these cerebrovascular accidents (Armstrong, Thompson, Wang, Zimmerman, Pegelow,
Miller, 1996). Recent literature suggests that children and adolescents with SCD and no
detectable neurological problems may also be at risk for neuropsychological problems,
which may impact their performance at school (Gold, Johnson, Treadwell, Hans,
Vichinsky, 2008; Noll, Stith, Gartstein, Ris, Grueneich, & Vannatta, 2001).
Although mortality rates have decreased in recent years due to newborn
screenings, prevention of infections, and improvements in medication and education,
statistics clearly demonstrate a decreased life expectancy among individuals with SCD
(Ashley-Koch, Yang, & Olney, 2000). Adolescents continue to remain at risk for death,
permanent disabilities, or infections (Armstrong, 2006).

Neuropsychological Sequelae
Neuropsychologists have recently begun to understand how SCD and the
associated medical problems can negatively impact neurocognitive functioning. There is
limited research exploring the neuropsychological effects of SCD among children and

adolescents. Advancing neuropsychological studies among individuals with SCD will
help provide a better understanding of the brain functions affected by the disease itself as
well as allow professionals to better accommodate the educational and psychological
needs of these individuals.

Neuropsychological Deficits
The biology of SCD may contribute to neurocognitive declines in intellectual
functioning (Steen, Fineberg-Buchner, Hankins, Weiss, Prifitera, Mulhem, 2005; Swift,
Cohen, Hynd, Wisenbaker, McKie, & Makari, 1989). Additionally, the gamut of medical
problems described above, such as cerebral infarctions, resulting from SCD has been
associated with cognitive deficits. These medical problems and associated
neuropsychological deficits will be explored more thoroughly in Chapter 11.
Neuropsychologists have played a significant role in addressing the
neurocognitive and emotional sequelae of SCD that arise fiom the vast amount of
medical problems associated with the disease. Specifically, neuropsychologists have
demonstrated that there are significant psychological and neuropsychological effects of
SCD in children and adolescents (Noll et al., 2001; Ris & Grueneich, 2000; Steen et al.,
2005). Hence, SCD poses a serious risk for academic and intellectual problems for this
developing population. Many of the findings address global effects of SCD on
neurocognitive functioning. There has not been sufficient explanation of specific
neurocognitive functions such as working memory.
In general, the research to date on chronically ill children has consistently
documented risks for psychoeducational and learning disorders (Lubker, Bemier, &

Vizoso, 1999). Indeed, several studies indicate that individuals with SCD perform lower
than their same-age peers without SCD on verbal and performance measures (Hogan,
Kirkham, Isaacs, Wade, & Vargha-Khadem, 2005; Noll et al., 2001). Additionally,
neuropsychological assessments and research have begun to increase knowledge of
specific neurocognitive domains derived h m theories of brain organization, such as
language, visual-spatial, and executive functions (Schatz & Puffer, 2006). Based on these
findings, it is crucial to understand the underlying neurocognitive functions and processes
which may contribute to learning disorders and other cognitive deficits in children and
adolescents with SCD.
The dearth of literature with regard to academic difficulties among children and
adolescents with SCD indicates a strong need to expand upon neuropsychological testing
in order to address the prevalence of learning deficits and provide appropriate
interventions (Peterson, Palermo, Swift, Beebe, & Drotar, 2005). In fact, Peterson and
colleagues contend that more information is needed with regard to daily school
functioning of children and adolescents with SCD, such as changes in attention and
memory. They also maintain that academic problems in the classroom are often
unnoticed by faculty and administrators or attributed to school absences. Understanding
these changes or deficits in daily functioning is crucial in order to provide appropriate
accommodations such as Individuated Educational Plans and Section 504 plans as well as
psychoeducation to the professionals involved in their everyday lives.
Processing speed and working memory have been considered significant
executive functions underlying many of these neurocognitive processes which are
essential to learning. A better understanding of the relationship among these factors in

children and adolescents with SCD will help to delineate the neuropsychological deficits
in individuals with and without Sickle Cell Disease. Of note, Schatz, Finke, Kellett, and
Kramer (2002) conducted a meta-analysis on cognitive functioning in children with SCD.
Their findings suggest that specific abilities are more sensitive than IQ scores to
cognitive impairments in children and adolescents with SCD. Thus, examining the effects
of SCD relating to cognitive fatigue, processing speed, and working memory among
children and adolescents will help to identify needs, appropriate recommendations and
accommodations, and interventions which will ideally foster learning.

Background
Sickle Cell Disease is a genetic disorder caused by a mutation of hemoglobin,
which has been traced to chromosome 11 (Ashley-Koch et al., 2000). The most common
types of sickle cell disorders are Sickle Cell Anemia (Hb SS), Sickle-Hemoglobin C
Disease (Hb SC), and Sickle Beta-Plus Thalassemia (HbS P-thalassemia) (Gustafson et
al., 2006). Hemoglobin, which is found in red blood cells, is responsible for helping
transport oxygen from the lungs to other parts of the body. Individuals with SCD are born
with cells that are affected by abnormal hemoglobin (Hb); mostly hemoglobin S, and in
other cases, hemoglobin C. This abnormality causes red blood cells to become distorted
in shape; these sickle shaped cells have difficulty passing through blood vessels, causing
less blood to reach various parts of the body. Vaso-occlusions, which result from sickle
cells obstructing blood flow, pose serious risks for children and adolescents including,
but not limited to, organ damage, neurological diseases, hypoxia, and severe pain
(Gustafson et al., 2006; Swain, Mitchell, & Powers, 2006). Anemia, tissue damage of the

lung, and stroke are also possible outcomes (Ashley-Koch et al., 2000). Further, a
significant proportion of strokes and infarcts occur during early developmental years or
before 14 years of age (White, Salorio, Schatz, & DeBaun, 2000).
Despite its historical prevalence with clinical findings dating fiom 1910, advances
in SCD research are quite recent. According to Armstrong (2006), knowledge about the
etiology, severity of symptoms, treatment, and management of SCD did not emerge until
the 1980s. Since that time, significant improvements have emerged, yet, to date, there is
no consistent cure for SCD.

Treatment Protocols
The treatment for SCD varies according to the needs of the patient. Once
diagnosed, children with SCD are recommended to schedule healthy routine doctor visits.
Routine immunizations and prophylactic medications are administered to children based
on their age (Lane, Buchanan, Hutter, Austin, Britton, & Rogers, 2001). Typical therapies
include medication, such as hydroxyurea, and in more severe cases, the use of bone
marrow transplants. Medications have been implemented in most treatment protocols to
help reduce pain symptoms (Ballas, Barton, Waclawiw, Swerdlow, Eckrnan, & Pegelow,
2006).
Immediate medical care is required under certain circumstances. Lane and
colleagues (2001) provide a comprehensive list of medical problems including pain,
respiration problems, abdominal pain, neurological signs or symptoms, fatigue, vomiting
or diarrhea, andlor priapism episode (i.e., a painhl condition in which an erect penis does
not return to its flaccid state). Transfusion therapy is also utilized during some acute

illnesses in patients with SCD. For example, acute vaso-occlusive episodes, exacerbated
anemia, and preparation for some medical procedures involving anesthesia, may warrant
red blood cell transfusions (Lane et al., 2001). In cases when severe anemia that lasts
over several days, termed aplastic crisis, individuals may be at risk for heart failure; thus,
a slower type of transfusion is needed.

The Biopsychosocial Developmental Perspective
As noted above, many of the neurological consequences of SCD and problems
associated with the disease place individuals at a greater risk for neurocognitive deficits
and developmental effects (Ris & Grueneich, 2000). Schatz and Puffer (2006) purport
that failure to include early developmental factors (e.g., birth risks, postpartum infection,
hypoxia), may overestimate the impact of the disease on cognitive functioning. The
biopsychosocial developmental perspective has facilitated a better understanding of SCD
and the interaction between the disease and associated problems throughout the
development of children and adolescents. This model has been considered the forefront
of both medical and psychological research as it allows for a comprehensive view of the
various factors affecting individuals with SCD: biological, cultural, social, emotional,
developmental, and contextual (Armstrong, 2006; Gustafson et al., 2006). When
performing neuropsychological assessments on children and adolescents with SCD, a
developmental perspective should be incorporated into the model. As Bernstein (2000)
notes, incorporating biology and development into models of assessment will provide a
better understanding of neurological disorders and will benefit patients. Therefore,

several of these components, including age, birth, and neurological history were included
in the current study.

Specific Executive Functions
Executive tinctions of the brain include a broad range of domains, including, but
not limited to planning, organization, shifting, self-monitoring, information processing
speed, working memory, and attention. These functions have been linked to the frontal
lobe of the brain and are essential to efficient learning. Specific executive functioning
domains have been examined considerably with the sickle cell population, with marked
differences noted in specific areas of dysfunction. For example, many researchers have
reported lower performance on memory and attention tasks (Fowler, Whitt, Lallinger,
Nash, Atkinson, & Wells, 1988; Ris & Grueneich, 2000) when compared to healthy
children. Notably, older children with SCD have been found to have lower scores than
younger children (Steen et al., 2005). Thus, decrease in performance with age has been
suggestive of cumulative effects of disease on the brain.
Brown, Buchanan, Doepke, Eckman, Baldwin, and Goonan (1 993) reported that
individuals with SCD demonstrate lower scores on tasks associated with executive
functioning, such as attention and impulsivity, when compared to healthy individuals.
The authors were unable to find support for an age-related decrement or sickle cell type
among the individuals or variability between the types of sickle cell conditions,
homozygous compared to heterozygous. Individuals who have inherited two copies of the
sickle cell gene are considered homozygous for the disease and have Sickle Cell Anemia,
while individuals who have inherited one copy of the gene ( k mone parent) are

considered heterozygous for the disease and have sickle cell trait (Ashley-Koch et al.,
2000). The inconsistent findings with regard to specific executive functions of
individuals with SCD and a possible age-related decrement need to be addressed with
additional research. In addition, the authors did not include working memory, which is a
significant component of neuropsychological assessment.
Vaso-occlusions (decreased oxygen and blood flow due to sickled cells) have
contributed to stroke in some individuals with SCD. Researchers have examined the
effects of stroke among sickle cell patients, often demonstrating a significant difference
in many cognitive domains between individuals with SCD who have experienced stroke,
compared to individuals who have no evidence of stroke and healthy controls. Possible
neuropsychological effects from medical events, such as a stroke, should be considered in
light of the patient's current age. The highest incident of the first stroke in a child with
SCD usually occurs between the ages of 2 and 5 years (Schatz & Puffer, 2006). Studies
have demonstrated that children who experience strokes tend to score significantly lower
on measures of intellectual functioning, when compared to individuals with SCD who
have no evidence of stroke.
In order to address the possible age-related decrement in specific neurocognitive
functions over time in children and adolescents with SCD, the present study on SCD
included neuropsychological assessment from a biopsychosocial-developmental
approach. The model focused on current age as a variable, and neurological history was
requested to assure that the healthy controls did not have any form of chronic illness or
any known history of disability. Individuals with SCD and a history of stroke were
excluded from the study. Only children and adolescents with either Sickle Cell type SS

and type SC were included in the Sickle Cell group. Individuals with Sickle Cell trait and
any other type of Sickle Cell, such as Sickle Beta-Plus Thalassemia, were excluded fiom
both groups due to the variations in their disease, which would likely have impacted the
presentation of cognitive symptoms.
Schatz and colleagues (2002) conducted a meta-analysis on cognitive functioning
in children with SCD. Their findings indicate that individuals with SCD and no cerebral
infarction demonstrate small, but reliable deficits on measures of IQ. In addition, the
authors contend that specific cognitive and executive domains may show a greater effect
than broad cognitive or intellectual domains alone. Therefore, examining specific
executive functions, such as working memory and processing speed are more informative
than solely relying on overall domains, which are not sufficient in researching individuals
with SCD and no cerebral infarcts.

Working Memoly

Working memory is a central component of complex cognition (Shah & Miyake,
1999). Working memory has been described by Baddeley and Hitch (1974) as a system
or mechanism underlying the maintenance of task-relevant information during the
performance of a cognitive task. Baddeley and Logie (1999) assert that working memory
is involved in central executive functioning. Working memory is involved in numerous
complex activities, including hut not limited to, mental arithmetic, reasoning and
language comprehensive. Thus, problems with working memory in individuals with SCD
may impede other cognitive processes.

Several researchers have studied working memory in individuals with SCD. For
example, Brandling-Bennett, White, Armstrong, Christ, and DeBaun (2003) examined
individuals with SCD who have experienced stroke and compared them to individuals
with SCD who have not had frontal cerebral infarcts, which are infarcts located in the
frontal lobe of the brain. Their findings indicated that those with fiontal infarcts have
greater impairment with regard to manipulation of information in working memory
(Brandling-Bennett et al., 2003). Another study by Brown, Davis, Lambert, Hsu,
Hopkins, and Eckman (2000) examined the neurocognitive functioning of children with
SCD who had either cerebrovascular accidents or silent strokes and were compared to
children with no evidence of CNS pathology, which is a leukemic infiltration of the
central nervous system. The data indicated that those with clinical strokes or silent
strokes performed more poorly than their peers without any stroke (Brown et al., 2000).
Children with SCD and no overt signs of CNS damage had lower scores on every
measure of cognitive functioning, including attention, memory, and achievement, when
compared to healthy control (Noll et al., 2001). However, findings were not significant
for working memory domains on the Wide Range Assessment of Memory and Learning
(WRAML). Based on these inconsistent findings, examining working memory in a
population with SCD and no known history of stroke is essential in the current study.
Understanding specific components, such as verbal working memory, may help
illuminate reported deficits in many areas, such as intellectual functioning, in children
and adolescents with SCD.
Processing Speed

Processing speed describes the rate at which basic cognitive operations can be

completed (Schatz, Kramer, Ablin, & Matthay, 2000). Processing speed has been
considered a sensitive measure of sensory and motor changes that affect cognition
(Salthouse, 1996). Because of the changes in cerebral blood flow among patients with
SCD, processing speed may be an important construct to examine as it has been recently
suggested that processing speed is correlated with cerebral blood flow. Processing speed
underlies cognitive functioning and learning and has been considered a necessary
component of working memory processes (Schatz et al., 2000). Some have considered
processing speed a sensitive measure of cognitive functioning because the proportion of
variance found to have been associated with differences in aging individuals has been
almost fully accounted for by scores on simple tasks of processing speed (Salthouse,
1996). Despite its significant role in cognitive functioning, minimal studies have
examined processing speed with SCD patients.
Several clinical populations other than SCD have been researched with regard to
processing speed and working memory. Research indicates that individuals with a history
of cerebrovascular accidents demonstrate impaired processing speed, while those patients
with SCD who do not show evidence of any cerebrovascular accidents may be at risk to
develop cognitive deficits, including slowed processing of information (Steen et al.,
2005). Moreover, of the 55 children studied by Moser, Miller, Bello, Pegelow,
Zimmerman, and Wang (1996) who experienced multiple lesions, the majority (78%)
were found to have frontal lobe lesions, an area associated with executive functioning.
Understanding the impact of SCD on these two variables, processing speed and working
memory, may lead to improvements in learning for children and adolescents diagnosed
with SCD.

A relationship between pain and processing speed has been documented,

indicating that individuals with chronic pain performed poorly on tasks of delayed
memory and information processing speed (Hart, Martelli, & Zasler, 2000). Similarly,
Lezak and colleagues (2004) reported that individuals who experience pain are likely to
demonstrate weaknesses in processing speed. Thus, in order to account for any impact of
pain on any of the processing tasks, pain was assessed by self-report prior to the
assessment. In addition, patients were monitored throughout the test for any complaints
of pain.

Cognitive Fatigue

Fatigue is a chief complaint among individuals with SCD. Mental or cognitive
fatigue has been conceptualized as difficulty performing certain mental tasks (Deluca,
2005). Deluca describes four possible approaches that exist when studying cognitive
fatigue in a clinical population: (a) cognitive fatigue over an extended time (prolonged
effect), (b)cognitive fatigue during sustained mental effort, (c) cognitive fatigue after
challenging mental exertion, and (d) cognitive fatigue after challenging physical exertion.
This definition of fatigue measures mental performance as a behavior, not as a subjective
feeling. Toward this end, fatigue reported by an individual's self-report of on a subjective
scale generally has little to no correlation with objective measurements, or behavior.
Cognitive fatigue has been defined as the inability to sustain performance
throughout the duration of a continuous, complex information-processing task (Bryant,
Chiaravalloti, & DeLuca, 2004). Several studies demonstrate that over time, cognitive
performance declines during mentally challenging tasks (DeLuca, 2005). The majority of

the clinical populations that have been studied with regard to cognitive fatigue includes,
but is not limited to those people diagnosed with multiple sclerosis, chronic fatigue
syndrome, depression, and traumatic brain injury (TBI). Most studies have examined
adult populations and, to date, no studies have examined cognitive fatigue among sickle
cell patients. In addition, due to the lack of consensus regarding definitions of cognitive
fatigue, the present study examined cognitive fatigue during sustained mental effort
among sickle cell patients.

Significance of the Study
SCD is a significant concern, particularly among African Americans in the United
States. The extensive medical problems and challenges faced by children and adolescents
with SCD have been associated with numerous problems, including academic difficulties
and neurological problems that may affect processes involved with learning.
Neuropsychological research on SCD remains limited. Researchers have demonstrated
significant findings with regard to global deficits among individuals with SCD,
particularly with regard to those who have experienced cerebrovascular accidents or
infarcts.
Even more limited is research regarding specific neurocognitive functions such as
processing speed and working memory among children and adolescents with and without
a history of stroke. Because these processes are associated with specific aspects of
learning, focusing on these processes may be advantageous when attempting to
understand cognitive dysfunction in the SCD population and provide appropriate
educational and academic accommodations and interventions. Therefore, the following

study examined two specific executive functioning components, processing speed and
working memory among individuals with SCD and no known history of stroke compared
to a sample of healthy controls.
Lastly, the goal of the current study was to be the first to examine cognitive
fatigue through an objective, rather than subjective method, among a sample of children
and adolescents with SCD.

Research Questions
1.

How do children and adolescents with SCD and no known history of

stroke differ in terms of processing speed and working memory, when compared to
healthy children and adolescents?

2.

How does SCD affect processing speed and working memory during

development? Specifically, is age related to the performance of children and adolescents
with SCD and no history of stroke on working memory and processing speed tasks?
3.

Are symptoms of cognitive fatigue more pronounced in children and

adolescents with SCD when compared to healthy children and adolescents?

Hypotheses
HI

Children and adolescents with SCD and no history of stroke will have

significantly greater deficits in processing speed and working memory than healthy
individuals.
H2

There will be significant differences between the SCD group and healthy

group on scores of processing speed tasks and working memory tasks when controlling

for age. In addition, there will be a specific impact of age on performance according to
these measures.
H3

Individuals with SCD and no known history of stroke will demonstrate

greater cognitive fatigue when compared to healthy participants.

Definition of Terms
Sickle cell disease: Includes individuals with either SCD Hb SS or Hb SC.
Sickle cell disease (Hb SS): Individuals who have inherited two copies of the

sickle cell gene, Hb S, a variant of the P-globin gene called sickle hemoglobin (Hb S);
individuals with this type are considered homozygous for the disease; also referred to as
sickle cell anemia (SCA).
Sickle-hemoglobin C disease (Hb SC): Sickle cell disease caused by one copy of

Hb S plus another P-globin variant, Hb C. Individuals with this type of the disease also
meet criteria for sickle cell disease (Ashley-Koch, et al., 2000).
Sickle beta-plus thalassemia (Hb SP-thalassemia): Individuals who inherit one

copy of Hb S plus another P-globin variant, Hb P-thalassemia. Patients with this type of
sickle cell disease will be excluded from the study.
Processing speed: Processing speed describes the rate at which basic cognitive

operations can be completed (Schatz, Kramer, Ablin, & Mattay, 2000).
Working memory: Working memory has been described as a system or

mechanism underlying the maintenance of task-relevant information during the
performance of a cognitive task (Baddeley & Hitch, 1974).
Cognitivefatigue: Consistent with DeLuca's (2005) definition of cognitive fatigue

during sustained mental effort, cognitive fatigue will be measured by decreased
performance on second half vs. first half of a sustained cognitive task.

Delimitations

The main limitation in quasi-experimental designs in research is with regard to the
sample. Because participants were predetermined based on their health status (i.e., SCD
without a history of strokes or healthy individuals), participants lack random sampling. In
an attempt to control for some threats to validity, the healthy group was included in the
present study. In addition, Pedhazur and Schmelkin (1991) note that subject selection and
statistical adjustments can help control threats to validity, such as confounding variables.
Toward this end, selection of participants was attempted to be selected based on similar
demographic information. Although the patient sample was representative of children
with SCD, the majority of these participants were from a low economic background.
Therefore, the sample may have impacted its external validity, as larger populations of
SCD may not necessarily have low annual income. With regard to generalizability, the
current study was limited to children and adolescents with sickle cell disease, particularly
types Hb SC and Hb SS. The results cannot be assumed to relate to literature on adults
with SCD, as development is a significant factor for the current population or other types
of sickle cell disease that were not included in the study.

CHAPTER I1
Review of Related Literature
The purpose of this chapter is to provide a critical review and discussion of the
literature relevant to the proposed study. Researchers have only recently begun to
examine the psychological and neuropsychological impact of SCD on intellectual and
cognitive functioning. Ample studies have provided evidence that SCD can cause
significant impairments in psychological, neuropsychological, and educational domains
(Lubker et al., 1999; Noll et al., 2001; Ris & Grueneich, 2000; Steen, Hu, Elliot, Miles,
Jones, Wang, 2002). First, this review will discuss those findings. Next, the
neuropsychological sequelae of SCD will briefly be discussed to provide a background
for specific executive dyshction. The susceptibility of two specific functions,
processing speed and working memory, to neurocognitive deficits will be examined &om
a biopsychosocial developmental perspective. Further, individuals without cerebral
vascular complications will be considered with regard to their neurocognitive functioning
due to the substantial findings regarding those with stroke. Lastly, cognitive fatigue, a
relatively novel construct in neuropsychological research, will be examined in light of
SCD.
Academic and Cognitive Functioning
Individuals with SCD have been found to perform lower on certain academic and
cognitive measures. While the disease itself may impact performance in school, other

factors such as fatigue, pain, and absences from school may contribute to educational
performance that is below children and adolescents true abilities (Peterson et al., 2005).
Demographic factors, such as socio-economic status (SES) and age, have also been
considered risk factors for children and adolescent's academic and intellectual
functioning (Bankat, Lash, Lutz, & Nicolaou, 2006). For example, some researchers
contend that financial difficulties among African American families may influence a
child's adjustment (Gustafson et al., 2006). Toward this end, research has indicated that
individuals from lower economic families tend to perform lower on cognitive and
standardized tests during preschool and school age years. Stage of development is also
believed to have implications for their academic performance. Thus, in order to account
for factors such as absences and demographic information, all efforts were made in the
current study to include comparisons of individuals with SCD to healthy individuals of
similar economic and ethnic backgrounds, and controlled for age due to the possibility of
cumulative effects on the brain over the course of development.
Brown and colleagues (1993) examined possible confounding variables and their
effect on cognitive performance. Specifically, the researchers measured social class, age,
sex, and disease severity on cognitive functioning. Seventy patients ages 2 to 17 with
SCD were examined and matched with 18 healthy siblings as controls. Any child with
neurological difficulties was eliminated from the study. Findings indicated that children
with SCD performed significantly lower than their siblings on specific areas of

functioning, particularly on measures of academic achievement and sustained attention.
Intellectually, however, the children with SCD performed adequately. These findings
indicate some evidence of frontal lobe involvement, which is particularly relevant to the

current study due to the role of the frontal lobe in specific executive functions. With
regard to demographic variables, minimal evidence supported the notion that
performance decreases with age; however, visual-motor functioning and sustained
attention were found to decrease as children developed. Socio-economic status (SES)
was found to be moderately related to the measures given, which demonstrates that that
SES may contribute to some of the variability in cognitive functioning. More importantly,
however, when SES was controlled, hemoglobin was found to be predictive of
intellectual functioning, fine motor skills, whereas academic achievement and school
absenteeism was not related to academic or intellectual functioning. Overall, the article
l in functioning of children and
provides important evidence of the role of the ~ o n t alobe
adolescents with SCD. Yet, a small number of controls was utilized in the sample, which
should be expanded and examined further. Further, the age range included in the study
may not have been extensive enough to examine the developmental effects of SCD.
The Hematology/Oncology Psycho-Educational (HOPE) Needs Assessment has
facilitated in the understanding of those patients who are in need of educational
interventions, neuropsychological evaluation, and academic planning. Peterson and
colleagues (2005) utilized the HOPE assessment with 72 children and adolescents, ages
five to thirteen. Overall findings indicated that regardless of sickle cell type and history
of stroke, one-third to one-half of the individuals assessed were found to have significant
academic needs and limitations, behavioral problems, and changes in attention or
memory. This study is particularly relevant to the current study, because it provides
evidence that more developmental screenings are needed. The authors purport that
discrepancies between educational needs and school interventions remain, which alludes

to the importance of not only providing recommendations, but also pragmatically
following through with the recommendations through an educational liaison. The
importance of neuropsychological assessment with a school-age SCD population is also
stressed, and the authors provide suggestions for securing appointments with a minority
population who often experience difficulty with transportation as well as the
understanding of the need for a neuropsychological evaluation.
Cognitive and neuropsychological research is relatively new among the sickle cell
population. Several researchers have compared children and adolescents with SCD and
cerebral vascular accidents (CVA) to those with SCD and no evidence of CVA to better
demarcate the effects of SCD on the brain, without interference from CVA.
Armstrong and colleagues (1996) were some of the original researchers of
cognitive functioning in SCD patients for the Cooperative Study of Sickle Cell Disease, a
multicenter study. The authors' final sample included 194 patients, ages 6 through 16,
with mostly HbSS represented in the sample. The study included a neuropsychological
evaluation and MRI of the brain for each subject, and individuals were categorized based
on cerebral infarction, atrophy, or healthy condition. In additional to neuropsychological
domains, the researchers examined eight factors, four of which were significantly related
to neuropsychological functioning: language spoken at home, parent education, age, and
hematocrit levels (which measures the proportion of blood volume that is occupied by red
blood cells) were used as covariates in the analyses. Overall findings of the
neuropsychological assessment indicated that children with cerebral infarcts performed
significantly lower than children with silent infarcts and children with no MRI
abnormalities on global cognitive functioning, specific areas of language and verbal

abilities, visual-motor and visual-spatial processing and performance, and academic
achievement. They also scored lower than children with no MRI abnormalities on visual
motor speed of processing and sequential memory.
A significant finding in this study was that the majority of individuals with
cerebral infarcts had Hb SS type of SCD. In addition to their pervasive impairment,
individuals with silent infarcts performed poorer than healthy children on arithmetic,
vocabulary, visual motor speed, and coordination. Thus, the authors provide sound
evidence for inclusion of the genotype of SCD. The authors also helped to identify the
locations of cerebral or silent infarcts by utilizing MRIs and neuropsychological research,
which was determined mostly across the frontal cortex and basal ganglia; however,
instruments utilized in the study, including the WISC-R, are now outdated. Thus, current
assessments are needed. Additionally, the authors failed to examine developmental trends
in performance, despite their acknowledgement that several studies provide evidence of
impairment due to cumulative effects of infarcts over time. While individuals with
infarcts demonstrated sequential memory problems, more extensive assessments of
children and adolescents with SCD with and without infarcts should be studied.
Brown and his colleagues (2000) extended the study by Annstrong and his
colleagues (1996) including SCD patients without any evidence of CNS damage.
Children and adolescents were administered neuropsychological assessments along with
magnetic resonance imaging (MRIs). MRI readings were classified as normal (without
any CNS damage), cerebral infarction, atrophy, cerebral infarction and atrophy, or silent
stroke. Six domains were assessed in the neurocognitive battery: intellectual functioning,
academic functioning, attention and executive functioning, language, visual-spatial and

motor processing, and behavior (Brown et al., 2000). Six MANOVAs on each
neurocognitive domain and post hoc analyses yielded several statistically significant
results. Children with overt strokes performed lower on attention tasks than those without
any CVA. Those with silent strokes performed similarly to those with overt strokes. The
unique finding of this study is that both groups with CNS involvement demonstrated a
high frequency of frontal lobe impairments revealed on the MRI. Thus, executive
functioning and attention measures may be useid tools when working with children and
adolescents with SCD, in order to screen for possible infarcts. Moreover, given the cost
of magnetic imaging tools, the current study provided support for cases in which MRIs
are not cost-effective. The authors were unable to demonstrate significant findings on
global measures of cognitive functioning, academic functioning, or visual-motor
functioning, which suggests that specific measures of cognitive functioning may be a
more viable option. This study by Brown and his colleagues (2000) further supports the
need for assessing specific executive functioning, which is being addressed in the current
research study.
Cognitive dysfunction has also been found among children with SCD and no
evidence of cerebral infarcts as evidenced by standard imaging when compared to
healthy, unrelated individuals of the same age, race, and gender. Steen and colleagues
(2005) examined 98 children, with an average age of 10.9 through administration of the
WISC-111. Children with SCD performed lower on measures assessing the Full Scare IQ
as well as the Performance IQ. An important component included in this study was
parental level of education. When compared to healthy patients, children with SCD still
performed lower than their healthy peers who had parents with minimal education.

Moreover, no significant findings were evident between children with or without stroke,
which contradicts much of the literature. While this study provides strong evidence for
global deficits in children with SCD without stroke, the majority of the sample consisted
of SCD type HbSS, indicating that individuals who have two inherited genes of sickle
cell and have sickle cell anemia, may be at greater risk for impairment. The results,
however, cannot be generalized to other types of SCD. Further, the findings were unable
to demonstrate evidence of any of the underlying mechanisms which contribute to these
global measures; therefore, the research does not address any specific areas of weakness.
Thus, a more comprehensive battery would have been informative.

Specific Neuropsychological Functions
In the following section, the neuropsychological sequelae of SCD will briefly be
reviewed and discussed in order to provide a background for specific executive
dysfunction.
A comprehensive neuropsychological battery was utilized in a study by Swift and
colleagues (1989). Participants in the study consisted of 33 children between the ages of
7 and 16 years with homozygous sickle cell anemia and no history of any neurological

complications. The battery included the WISC-R, the Beery Developmental Test of
Visual Motor Skills, the Social Competence Scale, the Achenbach Child Behavioral
Checklist, subtests from the Detroit Test of Learning Aptititude-2, and the WoodcockJohnson Psychoeducational Battery. Overall, children with SCD scored one standard
deviation below their siblings on measures of IQ, although only a very small number
performed in the Borderline range. Children with SCD demonstrated deficits in attention,

memory, verbal function, perceptual organization, and academic functioning. The SCD
group did, however, perform adequately with regard to visual-motor skills. These
findings are significant because the authors demonstrate that children with SCD and no
identified CNS damage may have difficulties in several neuropsychological domains,
which could impact their performance in school. Of particular relevance is performance
on memory tasks. Working memory, as evidenced by poor scores on digit span task on
the WISC-R, was one of the significant findings, and this will be examined further in the
current study. The susceptibility of two specific functions, processing speed and working
memory, to neurocognitive deficits will be examined from a biopsychosocial
developmental perspective, including their functioning with regard to development.
Further, individuals without cerebral vascular complications will be examined in light of
their cognitive and neurocognitive functioning.

Working Memory

Few researchers have begun to examine the underlying specific functions that
contribute to impaired performance on academic and cognitive measures. BrandlingBennett and colleagues (2003) studied verbal long-term and working memory in children
with SCD and frontal infarcts. Episodic memory has been defined as momentary
experience locked in one place and one time (Shimamura, 2002). They examined 10
children with SCD and cerebral infarcts and 21 children with SCD without infarcts, the
control group. The California Verbal Learning Test- Children's Version (CVLT-C) was
used to assess long term episodic and learning memory. Of the 5 trials, children with
infarcts recalled fewer words than the control group. No differences were found with

regard to recognition on any of the tasks. Thus, the authors concluded that memory
retrieval was impaired for the group with infarcts, but that encoding and storage were
adequate in both groups.
Working memory was assessed with the Digit Span of the Children's Memory
Scale (Brandling-Bennett et al., 2003). No significant differences were found on the
digits forward task; however, the group with infarcts performed significantly lower on the
backward digits span. The authors reported that children with SCD demonstrate an
impaired ability to manipulate information in working memory. Overall, these findings
are significant in that they suggest that children with SCD and frontal cerebral infarcts
evidence some executive dysfunction, which is reported to have resulted from the infarcts
which impacted the frontal brain region. The authors did not include any nonverbal
memory tasks nor did they include developmental factors, such as possible age-related
decrements in working memory and verbal learning.
Verbal working memory in children with SCD was also studied by White and
colleagues (2000). Similar to the study by Brandling-Bennett and colleagues (2003)
children with SCD and stroke were compared to children with SCD and no stroke. Prior
to this study, minimal investigations examined the location of lesions through MRIs and
their subsequent effects on specific cognitive performance. These authors included
children with anterior and posterior infarcts, which revealed significant findings
regarding patterns of working memory based on the location of infarctions. Specifically,
individuals with anterior infarcts demonstrated a tendency to recall reduced word lengths,
while the control group and the group with posterior infarcts performed adequately.
Those with anterior infarcts performed equally well on overall span. These findings

provide evidence of possible dysfunction of the phonological loop of the working
memory system, but an intact central executive component of this system.
An important consideration is that age at which infarcts occurred was not

available to the researchers; therefore, the authors were unable to determine if the infarcts
were new or old. This creates difficulty when trying to understand the impact of the
lesions on neurocognitive performance. For example, if some of the children had
experienced multiple infarcts, then their performance may have been more impaired than
a child with one infarct. Lastly, the authors used a small sample size, which will be
addressed in the current study.
Schatz and Roberts (2005) studied working memory and short-term memory span
in children with SCD, and included both auditory and visual processing. Twenty five
children with SCD and twenty five healthy controls were assessed and matched for age,
household income, and levels of parental education. The battery of tests included the
Wechsler Intelligence Scale for Children-Processing Instrument (WISC-PI), the Self
Ordering Pointing Test, the Category Fluency test from the Delis-Kaplan Executive
Functions Scale (D-KEFS), and a number of subtests from the Woodcock Johnson
Psychoeducational Battery-Revised (WJ-R). Of particular relevance to the proposed
study was the inclusion of a measure of processing speed as measured by Visual
Matching on the WJ-R, which is often lacking in the literature.
The group with SCD demonstrated lower scores on several measures: Oral
Vocabulary, Incomplete Words, and Visual Matching tests. They also scored lower on
Digit Span (backward), but performed adequately on all of the other span tests. Thus,
individuals with SCD demonstrated working memory deficits, particularly with

manipulating verbal information in memory as well as difficulties with processing speed
of information. The majority of individuals with SCD demonstrating these impairments
had a history of transient ischemic attacks or severe headaches. Thus, the authors
concluded that neurological symptoms may have contributed to the lower scores for this
subgroup of the sample. The sample of this study was limited, however, to individuals
with SCD, the majority of which had a history cerebrovascular impairment. The current
study will expand to this body of literature by examining individuals with SCD without
any known history of stroke, on the premise that the disease itself, regardless of stroke,
may also cause cognitive impairments.
The authors provide sound evidence for examining digits span forward and digits
span backward separately, indicating that the processing memory component involved
are separate and distinct modalities within central executive functioning processing. The
authors were not, however, able to provide any fiuther evidence regarding the extent to
which these modalities are involved. The findings were reported to be consistent with
previous literature maintaining that the modality specific rehearsal systems are involved
in with digits forward and digits backward tasks.
Although significant, the majority of the findings with regard to impaired working
memory consisted of individuals with SCD and transient ischemic attacks. In terms of
children and adolescents with SCD and no cerebral infarcts, several authors have reported
mixed outcomes with regard to working memory functions in children with SCD and no
cerebral infarcts. For example, No11 and colleagues (2001) studied children with SCD
with no evidence of cerebral infarcts and compared them to healthy individuals with
similar race, gender, and age. Overall, children with SCD scored significantly lower than

healthy children on several neuropsychological measures of performance on verbal,
spatial, achievement, attentionlmemory, and fine motor skills. Unique to this study, the
authors conducted a factor analysis across the five domains mentioned above, in order to
discern the discrepancies between the domains. The authors demonstrated mixed findings
with regard to working memory. Children with SCD performed lower than their healthy
peers on overall measures of attention and memory; however, children with SCD only
performed significantly lower on some working memory tasks as measured by the
WRAML. While the SCD group performed significantly lower on the Verbal IQ scale on
the WISC-R, authors failed to report the specific scores on subtests, such as Digit Span.
Therefore, inferences about the performance on this working memory task which
contributes to the overall verbal IQ score cannot be made. Although the authors provide
evidence of deficits among children with SCD and no cerebral infarcts, they purport that
several possible medical conditions may have contributed to the general findings.
Hypoxia, chronic anemia, and silent strokes were all considered possible factors for the
deficits, yet these remain conjectures as the authors had not accounted for silent strokes
in their methodology. Further, since demographic variables were not factored into the
analysis, the individuals who came from primarily disadvantaged environments may have
demonstrated scores which were overstated due to economic and educational differences,
rather than solely performance differences on tasks.
Bernaudin,Verlhac, Freard, Roudot-Thoraval, Benkerrou, and Thuret (2000)
conducted a multicenter study using transcranial Doppler ultrasonography, blood
screening, cerebral MRI, and neuropsychological evaluation among 173 children ages 5
to 15 and 76 sibling controls. Of those children with SCD, 21% had abnormal MRIs.

Significant impairments in cognitive functioning were demonstrated with individuals
with overt and silent stroke. In addition, low hematocrit levels were associated with
cognitive deficits. Overall findings suggested that Full Scale IQ and Verbal and
Performance IQs were lower in the SCD group when compared to their healthy siblings.
Specifically, the digit span task fiom the Verbal Scale and processing speed score on
Performance scale were significantly different. Afier exclusion of the group with overt
strokes, however, no significant differences were found with regard to cognitive
functioning. Thus, the majority of patients with deficits tended to have cerebral
impairments.

Processing Speed

As noted earlier, processing speed is considered a sensitive measure of
neuorocognitive functioning and it may be impacted by changes in cerebral blood flow
among the SCD population.
Steen, Xiong, Mulhem, Langston, and Wang (1 999) purported that individuals
with SCD and no evidence of infarction or injury remain at risk for cognitive
impairments. They compared individuals with SCD to healthy individuals. MR imaging
and hematocrit levels were included in their analysis. Overall, individuals with HbSS
demonstrated the lowest levels of cognitive performance. In addition, those with lowest
levels of hematocrit demonstrated greater cognitive impairments in all cognitive domains,
except for processing speed.
Bernaudin and colleagues (1 999) utilized similar techniques including blood
screening, transcranial Doppler ultrasonography, cerebral magnetic resonance imaging,

and neuropsychological evaluation by the WISC-111 and WPPSI-R with children with
SCD siblings on several measures, including Full Scale IQ and Performance IQ. Specific
subtests such as Digit Span, Coding, and Symbols were also significantly lower in the
SCD group when compared to healthy siblings. The findings demonstrated clear
disturbances on processing speed and working memory among the SCD group when
compared to healthy individuals.

In addition to the differences between SCD and siblings on several measures,
individuals with overt strokes performed significantly lower on the Full Scale IQ and
Performance IQ and patients with silent strokes performed lower than SCD patients
without strokes on verbal measures. However, there were no significant differences
between processing speed and working memory in groups with overt or silent strokes.
Processing speed and working memory was found to be significantly lower in
severely anemic patients, indicating that hematocrit contributes to processing speed and
working memory. Platelet count was correlated with cognitive performance, including
working memory, but not processing speed. Based on these findings, it appears that
processing speed and working may be a sensitive measure of cognitive functioning in
individuals with SCD, particularly those with low levels of hematocrit.
Steen and colleagues (2005) later examined the cognitive functioning of
hemoglobin SS patients without any known history of clinical stroke. The examiners used
MRI findings and hematocrit levels in their analysis. Individuals with lower levels of
hematocrit and cognitive impairments as measured by MRIs demonstrated greater
impairments on several subtests on the WISC-111, including several verbal and
performance tasks. There were no impairments on measures of processing speed.

Although processing speed was not impaired for individuals with or without silent
strokes, the findings are pertinent to the current study. The authors demonstrated that
individuals with SCD and silent strokes as well as individuals with SCD and no evidence
of cerebral vascular injuries experience cognitive impairments across various domains,
when compared to normative data. These findings contribute to the body of literature
with conflicting findings across neurocognitive domains. It is important to note that the
older instnunents, the WISC-I11 and WISC-R, were used in the study. Of further
relevance are the findings that MR imaging and hematocrit were both independent
predictors of Full Scale IQ. Thus, it is possible that hematocrit levels and MR imaging
may influence specific cognitive functions that comprise the Full Scale IQ.

Age-Related Decrement
As noted in Chapter I, research has documented that older children with SCD
have lower scores than younger children across various cognitive measures. The
decrement has been postulated as a possible result of cumulative effects of the disease on
the brain. Brown and colleagues (1 993) assert that cognitive impairments in older
children could provide evidence of cumulative damage to developing CNS. However, to
date, findings remain unclear as to whether insults during CNS development in children
with SCD become more pronounced in adolescence and early adulthood.
Brown and colleagues (1993) compared children with SCD to healthy children.
The authors postulated that an age decrement would be found in children with SCD.
Academic achievement and sustained attention were impaired in the SCD group. The
only cognitive domain found to have decreased with age was visual-motor functioning.

The authors were unable to find support for an age-related decrement or sickle cell type
among the individuals or variability between the types of sickle cell conditions
(homozygous compared to heterozygous). As in many previous studies mentioned,
hemoglobin was found to be a predictor of academic and cognitive functioning. The
authors also found that children with SCD performed similarly, in the Low Average
range, on tasks measuring expressive and receptive languages and visual-motor
functioning, which made comparison difficult for these domains. Therefore, controlling
for the effects of SCD as well as other chronic illnesses with the family or utilizing a
control group outside the family, which was conducted in the present study, is necessary.
Fowler and colleagues (1988) found that children with SCD (Hb SS) performed
lower on tests of reading, visual-motor skills, and attention compared to healthy peers
who were matched according to age, sex, race, and socioeconomic status. In addition to
the work by Brown and colleagues (1993), older children with SCA demonstrated lower
scores than younger children with SCA on visual-motor and attention tasks, suggesting a
cumulative disease effect. Notably, performance scores were not significantly related to
disease severity. Each child was scored on disease severity based on a neurodevelopmental examination across 10 items, including muscle tone, overall neurological
status, and cerebellar function. The authors assert that this insignificant finding suggests
that more subtle factors, such as silent infarcts, may have impacted the decrease in
performance over time. Also, SES was correlated with academic performance. Although
academic performance is not included in the current study, SES will be taken into
account.

In a study conducted by Wang, Enos, Gallager, Thompson, Guarini, and
Vichinsky (2001), children with SCD and silent infarcts performed significantly lower
than children with SCD without any type of infarct. Their study concluded that there was
a significant decline on the VIQ of the WISC-RIWISC-111 as well as the mathematics
subtest of the Woodcock Johnson, with increasing age, among individuals with SCD
without MRI abnormalities.
Kral, Brown, Nietert, Abboud, Jackson, and Hynd (2003) examined the
relationship between blood flow velocity as measured by Transcranial Doppler and
neuropsychological functioning. A regression analysis indicated that age was a
significant predictor of Full Scale IQ, VIQ, sustained attention, visual working memory,
and executive functioning. With respect to an age-related decrement, performance on
measures of intellectual functioning, sustained attention, and executive functions
decreased with increasing age among the sickle cell group.
Steen and colleagues (2005) found that cognitive ability as measured by the Full
Scale IQ of the WISC-111 tends to decrease as patients age; these results were not found
with the healthy controls in the study. All patients in the study had Hb SS and no MRI
findings. Thus, there is some indication that the decrease with age suggests cumulative
effects of disease on the brain.
A meta-analysis was conducted to examine cognitive functioning in children with
SCD and no evidence of cerebral infarction (Schatz et al., 2002). The analysis included
an evaluation of a possible decline in cognitive functioning with increasing age. The
authors report that decline in cognitive functioning with increasing age exists. However,
they caution that these studies may have been affected by possible confounding factors.

Therefore, the findings regarding age decrements should be considered as suggestive of
cumulative effects, not accepted as definite result. In addition, the authors suggest that the
age range in many of the studies reviewed was too limited, such as ages 7 to 12, and
should be expanded from to a wider range to include younger children up to older adults.
The current study will include children and adolescents aged 9 to 22 in order to address
this concern.
One study compared performance on intellectual, academic, and
neuropsychological functioning among children with SCD and no overt stroke to their
siblings (Wasserman et al., 1991). In contrast to findings of an age-related decrement,
children younger than 13 with SCD actuallyperformed significantly lower than older
children on measures of visual skills, expressive speech, writing, reading, and memory.
Swift and colleagues (1989) examined children ages 7 through 16 with HbSS and
no neurological disturbances and compared them to healthy siblings. Overall, individuals
with SCD scored approximately 1 standard deviation below their siblings on cognitive
measures. The authors did not find a relationship between levels of hemoglobin and
cognitive performance, nor were they able to find a decline in performance over time. In
fact, they assert that the results indicate impairments before the age of seven and purport
that additional variables influenced the cognitive impairment in those with SCD.
In sum, the inconsistent findings with regard to working memory, processing
speed, and a possible age-related decrement among individuals with SCD, clearly warrant
the need for additional research.

Cognitive Fatigue
Fatigue is truly a complex symptom because it can involve physical components
medical conditions, and psychiatric states (DeLuca, 2005). Although fatigue has been
studied for centuries, there is a lack of uniformity with regard to the definition.
Specifically, some definitions allude to a more subjective measure of cognitive fatigue,
while others are more objective.
Cognitive fatigue is a relatively novel construct in neuropsychological research.
DeLuca (2005) indicates that measures of mental or cognitive fatigue can be discerned
from physical or muscular fatigue, in that the former assesses concentration, while the
latter assesses feelings associated with weakness or a weakened physical state. As
discussed in Chapter I, cognitive fatigue has been classified into four major types. The
current study will examine cognitive fatigue during sustained mental effort. An example
of this definition in a clinical setting would include reduced cognitive performance during
a sustained mental task, such as a working memory task.
Research on cognitive fatigue during sustained mental effort has mainly been
conducted with specific medical conditions, mainly those patients diagnosed with
multiple sclerosis (MS), traumatic brain injuries (TBIs) and chronic fatigue syndrome
(DeLuca, 2005).
Schwid, Tyler, Scheid, Weinstein, Goodman, and McDermott (2003) conducted a
pilot study to examine cognitive impairment in individuals with MS using the Paced
Auditory Serial Addition Test (PASAT) and the Digit Ordering Test (DOT), each a
measure of continuous working memory sustained attention. Results were found to be
unreliable on the DOT. Patients with multiple sclerosis demonstrated a 5.2% decline in

performance on the PASAT, while healthy participants did not demonstrate any
significant declines.
Similar methodology was used by Bryant, Chiaravalloti, and DeLuca (2004). The
researchers examined cognitive fatigue during the Paced Auditory Serial Addition Test
(PASAT), a continuous working memory task among individuals with multiple sclerosis
(MS) and matched healthy participants. Cognitive fatigue was measured comparing
performance over the second half of the trails on the PASAT to performance during the
first half of the trials. Individuals with MS were grouped as cognitively impaired or
cognitively in-tact according to performance following administration of
neuropsychological measures. Both cognitively impaired and non-impaired individuals
with MS performed similar to healthy participants with regard to correct responses on the
PASAT. Notably, as working memory demands increased, both MS groups demonstrated
cognitive fatigue earlier than healthy individuals.
Consistent with the above noted definition of cognitive fatigue during a sustained
mental effort, Krupp and Elkins (2000) studied cognitive fatigue in patients with MS. The
researchers administered two brief repeatable neuropsychological batteries which were
separated by a continuous cognitive task, the A-A tasks. Comparisons of the two batteries
indicated that during the first administration, no significant differences were found
between the patients with MS and the healthy participants. However, following the A-A
test, patients with MS demonstrated sipificantly lower scores on three measures. In
addition, patients with MS demonstrated slowed reaction time in the second half of the
A-A test, when compared to the group of healthy individuals. The authors failed to

include the number correct for the A-A test, which would have been more indicative of
actual decrease in performance. Instead, they only included speed on the tasks.
Several of the studies that have examined cognitive fatigue have utilized selfreport measures; therefore, many of the results can be considered subjective and not
quantifiable. This newer definition of cognitive fatigue during sustained attention tasks
demonstrates many significant results in certain clinical populations. However, to date,
no studies have examined cognitive fatigue among individuals with sickle cell disease.
Specifically, the current study will investigate the impact of cognitive fatigue on a
sustained attention task.

summary

The purpose of this chapter has been to provide a critical review and discussion of
the literature relevant to the current study. This chapter included a section pertaining to
overall academic and cognitive functioning among the SCD population. An overview of
specific neuropsychological sequelae from a biopsychosocial developmental perspective,
which underlies the theory for the current proposed study, was provided. Two specific
neurocognitive functions, which will be analyzed in the current study, were reviewed in
light of the dearth of literature among the SCD population. Although findings appear
consistent with regard to strokes and their impact on specific neurocognitive functioning,
it remains unclear how the disease itself without the impact of strokes, may affect
specific functions, such as processing speed and working memory. These findings are
conflicting.

The theory that SCD may cause cumulative effects on the brain, resulting in
cognitive impairment over time, was also reviewed. While evidence has been provided
that older children and adolescents may demonstrate greater cognitive impairment than
younger children, other researchers (Brown et al., 1993) were unable to find evidence for
an age-related decrement. Overall, the literature remains unclear as to whether insults
during CNS development in children are more pronounced during adolescence and early
adulthood. Thus, the present study will include an analysis focusing on age differences
for specific functions, processing speed and working memory.
Lastly, cognitive fatigue, a novel construct in neuropsychological research was
discussed. Substantial evidence was provided with regard to the need for more objective
measures of cognitive fatigue. The current study will employ an objective measure
conceptualized and assessed by DeLuca (2005). In addition, the current study is the first
to examine cognitive fatigue among individuals with SCD.

CHAPTER 111
Methodology
The purpose of this chapter is to explain the methodology that was implemented
in the current study. Specifically, this chapter provides a detailed description of the
population of interest, the method of sampling, data collections methods, the assessment
instruments utilized, and a discussion of the reliability and validity for each of the
measures. Lastly, the study design, hypothesis testing, and statistical analyses for all
hypotheses are reviewed.

Participants
The current study focused on minority children and adolescents with sickle cell
disease (SCD) without any known history of stroke compared to healthy children and
adolescents. Due to the relevance of the biopsychosocial model when conducting
research among a developing population, participants with and without SCD were
assessed based on similar demographic variables, such as SES andlor race, and ethnicity.
Specifically, 53 children and adolescents aged 9 to 22 were contacted if their diagnosis
consisted of either SCD Hb SS or SCD Hb SC. Of the 20 recruited and confirmed to
participate, 14 kept their appointments and completed the study. Individuals with sickle
beta-plus thalassemia (Hb S p-thalassemia) and sickle cell trait were excluded from the
study primarily because their medical complications tend to differ from the other two

groups included. Thus, their presentation of symptoms may vary and subsequently
manifest differences in cognitive functioning. In addition, upon review of the medical
record, a number of participants who had a documented IQs equal to or below 70 were
excluded from the study.
The control group consisted of 19 healthy individuals without any chronic illness
or documented disability. There were no controls that demonstrated IQ scores less than
70; therefore, all individuals tested were included.
Participants in the sickle cell group were recruited fkom a medical center in the
Northeast. Healthy participants were recruited through friends and family members of the
experimental group and through solicitation letters (see Appendix A).
Tables 1 presents demographic values aggregated by study group, respectively.
There were 33 participants (19 healthy controls; 14 SCD) recruited for this study. As can
be seen in Table 1, overall groups were generally well matched with regard to age,
gender, and parent education. Parents of patients had completed a mean of 13.1 years of
education (SD = 2.3), while parents of controls completed a mean of 14.7 years (SD =
2.0). The healthy control group (Mdn = $75k) reported a greater parental income than the
SCD group (Mdn = $30k).
Despite attempts to match the control group through the recruitment process, the
groups recruited were not well matched for race or SES. A chi-square analysis was run to
compare the number of Afican American participants in the SCD group compared to the
control group, which was predominately Caucasian. Table 2 demonstrates the
relationship which indicates significant group differences according to racelethnicity. As
expected, the SCD group was represented by a significantly greater number of African

American participants (n = 9),2(3) = 1 0 . 0 , ~= 0.02, while healthy controls were
predominately Caucasian (n = 13) and Hispanics were equally represented within the two
study groups (n = 4, per group).
Of the 14 participants with sickle cell disease, 12 (85.71%) had SCD type HbSS,
while 2 (14.29%) had SCD type HbSC. At the time of testing, patients ranged in age
from 10 to 22 (M= 15.4, SD = 3.7). Figure 1 lists the age distribution of the groups. Both
groups displayed variability with regard to age. The age distribution of the healthy group
was bimodal with 7 participants falling between 10 and 12 years, 4 falling between 13
and 17 years, and 8 participants between 18 and 22 years. The sickle cell group had 3
participants between 10 and 11 years, 8 between 13 and 17, and 3 between 18 and 22
years old.

Table 1
Demographic Characteristics ofthe Sample Aggregated by Group (n
Control (n = 19)

= 33)

SCD (n = 14)

Total (n = 33)

M

SD

f

M

SD

F

M

SD

f

Age

15.7

4.4

--

15.4

3.7

--

15.6

4.05

--

Parent Income (Mdn)

75k

--

30k

Parent Education

14.7

2.0

--

13.1

2.3

--

14.0

2.3

-.

#Lifetime Hosp.

0

0

--

35.1

34.3

--

15.3

28.4

--

Gender
Male
Female
RaceiEthnicity
African American
White
Hispanic
Caribbean

--

--

Table 2
Ethniciw by Study Group

Healthy

SCD

Total

2

P

African American

2

9

11

4.5

0.04

Caucasian

13

0

13

--

--

Hispanic

4

4

8

0.00

1.OO

Caribbean

0

1

1

--

--

Ethnicity

Note. Chi-square not computed for Caucasian (all Caucasian participants were in

Healthy group). Chi-square not computed for Caribbean (not enough valid cases, n = 1)

Healthy

I

I

Sickle Cell

-

Age

Figure I. Age Distributions According to Group

Procedure
Procedures for data collection were consistent with each participant. Approval
was initially granted through the medical center's Institutional Review Board and then
through Seton Hall University's Institutional Review Board to conduct research. Annual
renewal was granted through each of these institutional review boards to continue the
study until its completion.
Eligibility for the sickle cell group was based on patient demographic information
(i.e., age and diagnosis) that was found in an accessible database permitted for use by the
researcher. Individuals with SCD who met criteria for either type Hb SS or Hb SC were
considered for the study. I reviewed each chart for neurological history. Recruitment
letters were mailed to patients over 18 who met the criteria for inclusion in the proposed
study as well as to parentdguardians of those patients under 18 years of age. The letter
outlined the rationale for participation in the study, namely to gain better understanding
of the impact of SCD on learning and cognition. The letter informed participants that, in
exchange for allowing the researcher to work with the patient, the participant would be
offered a monetary gift card of $25 at the completion of the testing session (see Appendix
A).
Several steps were taken with each patient to maximize the possibility for
successful recruitment. After I sent initial solicitation letters, follow up calls were made.
During several instances, phone numbers were non-working numbers. In these cases, an
administrative assistant of the hospital department helped to obtain current contact

information. After the first round of phone calls, psychosocial team members who
worked with the recruitment population were assigned a set of patients and parents who
were the clinicians that typically work with families during their clinic visits. I then
made a follow up phone call once a family expressed interest to a staff member, to
schedule an appointment. For those patients who were not contacted in person via a staff
member, I made a final set of phone calls. No more than two messages were left per
patient.
I called each patient the night before the scheduled appointment to confirm the
appointment. As noted earlier, 20 patients were scheduled for appointments. Four of
these patients did not show for their appointment and two individuals did not show on
more than one occasion.
Healthy controls were identified by the patients and with solicitation letters (see
Appendix A). Specifically, patients and their parents or guardians were asked to refer
any friends or family members. If interested, they were provided with the solicitation
letter describing the procedure and offering the researcher's contact information.
Individuals who participated were scheduled by the researcher based on a time
conducive to the research assistant's schedule and patient's schedule. A single blind
study was conducted in that the researcher did not assess any of the participants. Two
doctoral level research assistants were blindly assigned to the participants. However,
given the difference in racial mix between the groups, some degree of being '%blind" was
likely lost with the control group as it is public knowledge that most people with these
types of sickle cell are of minority status. The two researchers were trained in advance by
the primary investigator and her supervisor to ensure mastery of the testing material.

The testing sessions were held on the hospital's premises. My supervisor or I
administered the consent and assent forms and reminded participants of the voluntary
nature of the study, which was also specified in the consent forms in the recruitment
letter. Either my supervisor or I met with the participant and his or her parentlguardian if
they were a minor, while the research assistant remained in a separate room. In addition
to stroke history, exclusionary criteria for the SCD group included a current self-report
index of pain greater than 5, which was assessed at the start of the testing session. Only
one patient reported pain level greater than five; therefore, the consent process was
terminated and he was deemed not eligible for the study.
Individuals aged 18 or older were not required to be accompanied by a parent or
guardian. Participants under the age of 12 were read an oral assent form. Once the child
gave his or her assent, the parentlguardian was required to co-sign the assent form and
was provided a copy of the adult consent form to assure their understanding of the study
to read and sign.
Individuals aged 12 through 17 were given an assent form to read and were
required to sign the assent form in order to participate. The parentlguardian was required
to countersign the document. My supervisor or I was responsible for giving patients
demographic forms to complete. Those participants under 18 were required to have their
parentlguardian complete the demographics form. Once assent andlor consent were
granted, the participant then met with the research assistant. The research assistant
administered the testing battery, which was completed with the research assistant without
a parentlguardian present in the room. Total time for completion of the materials was
approximately one hour.

Research Instruments
The research battery consisted of the following measures: (a) a demographic
form, @) the two subtests of the Processing Speed Index from either the Wechsler Adult
Intelligence Scale-Third Edition (WAIS-111; Wechsler, 1997) for participants older than
the age of sixteen or the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-

IV;Wechsler, 2003) for participants sixteen or younger, (c) the Working Memory
subtests of the Wide Range Assessment of Memory and Leaning-Second Edition
(WRAML-2; Sheslow & Adams, 2003), and (d) the Connors' Continuous Performance
Test I1 (CPT 11), Version 5 (Canners, 2000).

Psychological and Neuropsychological Instruments
Following are descriptions of each of the psychological assessments used in the
current study, along with psychometric data for each scale. Further, studies in which the
assessments have been validated will be reviewed.

Demographic Form
The demographic form was created for this study (see Appendix B). Participants
in the study were asked to provide their birthdate, age, gender, racelethnicity, current
grade, number of years of parents' education, approximate household income, age of
diagnosis, prenatal problems, all medical conditionsldiagnoses, type of sickle cell disease
if applicable, documented disabilities, history of strokes, current medications, number of
hospitalizations related to SCD in the past year and throughout one's lifetime, history of

stroke, current report of pain, and bone marrow transplant history. In order to ensure that
exclusionary criteria was met, questions related to this criteria (i.e. history of strokes,
transplant history, pain) were starred and participants were told to inform the researcher
immediately if they meet exclusionary criteria. None of the exclusionary criteria were
met and therefore the testing process continued for all of the participants.
The following is a description of the neurocognitive measures used in the current
study. The order of the measures below was counterbalanced to ensure that any order
effects of the study were controlled and then participants were randomly assigned to
design A-B-C, A-C-B, B-A-C, B-C-A, C-A-B, or C-B-A.

WechslerIntelligence Scale for Children-Fourth Edition and WechslerAdult Intelligence
Scale-Third Edition
The Wechsler Intelligence Scales were originally developed in the 1930s to
measure global intelligence and have since been revised to provide updated cultural
norms and constructs of intelligence and to provide additional reliability and validity
testing (Groth-Marnat, 2003). The WAIS-111 includes six Verbal subtests and five
Performance subtests and is normed for ages 16 to 89, while the WISC-IV which
includes a total of 15 subtests, is normed for ages 6 to 16 years, 11 months. The
reliabilities for the WAIS-111 are generally high. With regard to the current study, only
the core subtests of the Processing Speed Indices were utilized. The Processing Speed
Index consists of two subtests, Digit Symbol-Coding and Symbol Search with subtests
loading onto the Performance IQ.

Symbol Search is psychometrically a relatively good subtest for both the WAISI11 and the WISC-IV. Test-retest reliability was found to be high, .79 for the WAIS-I11
and .76 for the WISC-IV. The subtest also correlates highly with the Full Scale IQ and
Performance IQs for the WAIS and the WISC-IV.
Coding is a fair measure of general ability (g) for the WAIS-111 (S7) and WISCIV (.48). Test-retest reliability for the Coding subtest of the WAIS-111 is high (36) and
moderate for the WISC-IV (35) (Flanagan & Kaufman, 2004; Kauhan &
Lichtenberger, 1999).
The test-retest reliability coefficient for the Processing Speed Index is .87 (GrothMainat, 2003). Internal consistency reliability was also found to be high on the Full Scale
(.96) and the Performance Scale (.91) but was more variable with regard to the specific
subtests.
Research regarding the validity of the WAIS-111 was primarily derived fiom
research on the WAIS-R, such as correlations with ability and achievement tests (GrothMarnat, 2003). In addition to strong reliability and validity coefficients, several strengths
of the WAIS-I11 include normative cross-cultural data and an extended age range up to 89
years of age. Of particular relevance to the current study is strong clinical relevance and
empirical support for interpretation of scores. For example, (30th-Mamat suggests that a
low score on Processing Speed is clearly indicative of difficulty processing information
rapidly.
Overall limitations of the Wechsler scales include data supporting ecological
validity ((30th-Mamat, 2003). For example, minimal studies have examined subtests,
such as Digit Span, with performance on everyday tasks. With regard to processing

speed, lower scores may be related to a child or adolescent's level of motivation or poor
motor control. Thus, observing an individual's behavior across the testing will help
monitor these possible confounding factors.
The degree of validity of research data when using cognitive measures with ethnic
minorities has been considered culturally biased ((30th-Marnat, 2003; Ryan, Baird,
Mindt, Byrd, Monzones, & Morgello, 2005). In older versions of Wechsler Scales, such
as the WISC-R, when SES was controlled in statistical analyses, African Americans'
performance was generally reduced on IQ measures. Even with the development of
updated cognitive measures, researchers have demonstrated that African Americans tend
to perform lower than Caucasians on verbal and nonverbal assessments, when controlling
for education and SES and have provided evidence that using norms that are not
appropriate for minority populations may inflate levels of impairment on testing (Ryan et
a]., 2005).
Recent studies clearly indicate that updated versions of the Wechsler Scales
remain biased against minority groups. For example, Sattler (2008) reported that EuroAmerican children obtained a mean Full Scale IQ that was approximately 11.5 points
higher than African American children. Some researchers contend that the Processing
Speed subtests (Coding, Symbol Search) of the WAIS-111 and WISC-IV utilized in the
current study are less likely to contain biases than other measures (Groth-Marnat, 2003).
For example, Sanler found a much smaller discrepancy between Euro-American and
African or Hispanic American children on measures of Processing Speed and Working
Memory indices. In addition, African and Hispanic Americans performed about 3 to 6
points higher on the Working Memory and Processing Speed indices, compared to the

Verbal Comprehension and Perceptual Reasoning indices on the WISC-IV. Others
maintain that discrepancies in reading level and education are significant factors for
performance on several cognitive domains, including both processing speed and working
memory (Ryan et al., 2005).
Given that a significant percentage of children with SCD live at or below the
poverty level, SES has been found to be a significant predictor of cognitive problems for
children with SCD (Schatz & Puffer, 2006). In addition, in a recent study by Ryan and
colleagues (2005), social class and the educational quality were more indicative of
cognitive performance than raciavethnic minority status alone. As a result, normative
standards for cognitive assessment have been questioned given the psychosocial
advantages and privileges associated with the dominant group. These findings provide
significant implications for the current study, which did not adequately compare specific
raciallgroups according to the specific cognitive measures assessed. Thus, there are clear
inherent discrepancies between the SCD group and control group.

Wide Range Assessment of Memory and Learning-Second Edition

The WRAML-2 is an assessment battery applicable for with children and adults,
ages 5 to 90, which measures various types of memory (Sheslow & Adams, 2003). For
the current study, the tests which are designed to assess working memory were utilized.
Specifically, the Working Memory Index, which consists of two subtests was used
(Verbal Working Memory, Symbolic Working Memory). In terms of scoring, raw scores
for both the Verbal Working Memory and the Symbolic Working Memory tests, were

converted into standard scores (M= 10 and SD = 3) and an overall Index score was
calculated.
Norms for the WRAML-2 are based on the 2001 Census in terms of gender,
racelethnicity, education, and geographic region (Strauss, Spreen, & Sherman, 2006).
Internal reliability scores were found to be high for the index scores ( 3 6 to .92). Overall,
test-retest reliability for the Working Memory Index is also high (.80 to .89), while testretest reliability was found to be in the adequate range (.70 to.79) for the Verbal Working
Memory subtest and in the marginal range (.60 to .69) for the Symbolic Working
Memory subtest.
Data from the WRAML-2 was determined for several clinical groups compared to
matched controls. Significant differences were found with regard to memory among
many groups, including, but not limited to individuals with Alzheimer's disease, children
with learning disabilities, and adults with traumatic brain injuries. Despite the studies
conducted, researchers have recommended that more studies examining validity be
conducted because the instrument was published recently (Strauss et al., 2006).
Strauss and colleagues (2006) acknowledge that these subtests may be
advantageous over other working memory tasks. For example, the Verbal Working
Memory task may be suitable for children because of the use of animals and real objects,
as opposed to simply letters and numbers.
Despite the many strengths of the WRAML-2, some considerations are warranted.
Specifically, the Working Memory Index was found to be highly correlated with the
AttentiodConcentration Index, indicating that these tasks may not be measuring unique
constructs (Strauss et al., 2006).

Some researchers have noted that lowered scores on working memory tasks may
be attributable to anxiety or poor executive functioning (Groth-Mamat, 2003). Thus, an
individual's performance must be evaluated carefully and should be compared with other
measures which assess cognitive functions. Observing performance on other measures
and comparing it to the individual's behavior across vary tasks will help to discern if,
perhaps, lower scores are indicative of an executive problem or the result of behavior.
Another significant limitation is that minimal studies on the validity of the
WRAML-2 with minority populations have been published. However, it is important to
note that the authors accounted for bias by including an item bias analysis of subtests.
Moreover, factor analyses were conducted which revealed no effects of ethnicity on the
structure of the WRAML-2 (Strauss et al., 2006).
Overall, the WRAML-2 is considered a substantial tool for examining memory
impairment across a wide range of individuals, from early childhood through late
adulthood. However, given that there is a dearth of research on minority populations
when assessed with the WRAML-2, findings with regard to the Working Memory Index
in the current study should be interpreted carefully.

Conners Continuous Performance Test I1

The CPT I1 is a computerized measure of sustained attention for individuals aged
6 and older. The test consists of a short practice exercise prior to the main task to ensure
that the individual understands the task. Respondents are instructed to hit the space bar
(or click the mouse) whenever they see any letter on the screen, except for the letter 'X.'
The CPT includes inter-stimulus intervals of 1,2, and 4 seconds. The structure is

comprised of 6 blocks, with 3 sub-blocks each containing 20 trials. Stimuli are presented
at varied intervals, and the order of these inter-stimulus intervals vary, which yields
scores regarding performance on number of hits, omissions, and commissions, as well as
reaction time by block, reaction time by inter-stimulus interval (Comers, 2000).
For the current study, number of hits and reaction time were the variables
analyzed. Specifically, the number of hits and reaction time in the first half of the test, or
the first three blocks, were compared to performance in the second half of the test, or the
second set of three blocks.
Clinical norms are based on a sample of 2,686 individuals, ages 6 and older, of
which 378 individuals were diagnosed as having Attention Deficit Hyperactivity Disorder
(ADHD) and 223 individuals with varied neurological impairments. Strauss and
colleagues (2006) report very high split-half reliabilities for hit reaction time (r = .95) and
omissions (r = .94). Internal reliability was found to be marginal (Strauss et al., 2006).
Test-retest reliability was tested with a small sample consisting of 13 clinical cases and
10 non-clinical cases. Confidence indices for the clinical cases, ADHD and neurological
impairments, demonstrate good reliability. Coefficients were found to be in the low range
for Test-Retest stability (<.59), marginal range (.60 to .69) for Commissions, and high
range ( 3 0 to 39) for Omission.
Strauss and colleagues (2006) acknowledge limitations regarding the clinical
utility of the CPT 11. Toward this end, the authors note that only a small number of
studies have been conducted with clinical populations above and beyond the sample
discussed above. Further, they caution against using the CPT I1 as a diagnostic tool.
Lastly, the CPT I1 has been considered a better measure of executive functioning than

attention, due to the need for inhibitory responses when attending to stimuli (Strauss et
al., 2006).
While these are important considerations for utilization of the CPT 11, the current
study is not using this instrument for the assessment of ADHD. Rather, cognitive fatigue
is being assessed by comparing the number of hits and rates of responses across this
sustained attention task. Therefore, the strong reliability and validity coefficients for
variables included in the current study, number of hits and reaction time, indicate that the
CPT I1 is an appropriate tool to measure cognitive fatigue.

Research Design
The overall purpose of the current study is to compare differences in
neurocognitive functioning among children and adolescents with SCD and healthy
children. The majority of the information was obtained through standardized assessment
measures. According to Pedhazur and Schmelkin (1 Wl), quasi-experimental designs are
best suited for studies in which groups are formed based on the dependent variable, in
this case, chronic illness. In order for assessments to control for any confounding
variables, such as fatigue, the order of the instruments was counterbalanced, as described
earlier.
The present study attempted to identify specific neurocognitive differences
between individuals with SCD compared to healthy individuals. As previously noted,
specific neurocognitive functions, such as processing speed, working memory, and
cognitive fatigue, are domains in which minimal or no research has been conducted with
this specific population. These domains can be examined and best understood using

quantitative methodology, through quasi-experimental design. This study examined the
differences between groups' performance on specific tasks that measure the cognitive
domains discussed above. The study aimed to describe these differences in order to
provide more information about how children and adolescents with SCD may
demonstrate more struggles in learning when compared to individuals without a chronic
illness. Understanding these differences can provide invaluable information to
neuropsychologists, psychologists, and related disciplines about how to provide
appropriate interventions and accommodations for individuals whose cognitive
functioning has been impacted by SCD.
While the overall design for the current study could best be classified as quasiexperimental, there are differences in the approaches by particular type of hypothesis.
Each of the hypotheses follow the causal comparative method known as ex post facto
research because the presumed causes are based on existing influences rather than causes
that true manipulations of variables that might otherwise have causes the differences
(LaFountain & Bartos, 2002). The type of statistical analysis used to test each hypothesis
varies, as will be discussed below.

Hypothesis Testing and Power Analyses
Each of the hypotheses included in the current study are listed below, followed by
a description of each of the hypotheses that were examined. The statistical analyses that
were utilized to test each hypothesis are discussed. Further, as noted above, the
discrepancy between the control group and the sickle cell group according to race and
SES poses a major threat to the validity of the study. Therefore, group differences must

be interpreted with caution, particularly with regard to differences in demographic
variables between participants and controls and their potential impact on the outcome for
each analysis.

Hypothesis I
Children with SCD and no known history of strokes will have significantly
greater deficits in processing speed, as measured by the Processing Speed Index, and
working memory, as measured by the Working Memory Index from the WRAML-2,
when compared to healthy individuals.
A
A one-way multivariate analysis of variance (MANOVA) was used to test HI.
MANOVA is applicable when examining the statistical significance of the effect of one
or more categorical independent variables on a set of two or more dependent variables
(Weinfurt, 2001). In the current study, the independent variable was comprised of two
groups, SCD without a history of stroke@)and a healthy control group. The mean scores
of the index measures for Processing Speed and Working Memory was compared using
the MANOVA procedure. Specifically, the scores on the index scores for Working
Memory and Processing Speed were the two dependent variables. The original power
analysis yielded a minimum number of 42 subtests in order to conduct this statistical
analysis with a power of .80 and medium effect size (.25). However, as previously noted,
the present study recruited 28 participants. Inspection of post-hoc estimates of effect
(please refer to Chapter IV, Hypotheses Tested section for detail) and power reveal that
sufficient statistical power was present to appropriately test study hypotheses and there
was accordingly minimal risk for Type I1 error. In brief, the study was adequately

powered to examine the primary hypotheses and insufficient sample size would not likely
serve as a threat to internal validity of this study. Instead, the heterogeneity of groups
posed a greater threat to validity.
A post-hoc power analysis (i.e., using G*Power) was conducted in order to
understand actual observed power for the statistical analysis conducted in Hypothesis I.
Using this methodology, actual observed effect size (d = 1.1), alpha (0.05), sample size
(n = 33), number of groups (two), and number of dependent variables (two) were entered
into the application which provided the actual power parameter of 0.99 (strong). Thus,
this post-hoc power analysis revealed sufficient power to detect significance.
Hypothesis 2

After controlling for age, children with SCD will continue to have lower scores
compared to healthy participants.
A one-way MANCOVA was utilized to estimate between-group differences on
each of the 2 scores on the tasks of neurocognitive functioning according to age. Age, a
continuous variable in this model, was the covariate in the analysis. Power analysis
yielded 42 participants with a medium effect size of S O and two independent variables
and 1 covariate. Similar to Hypothesis I, post-hoc power analysis was conducted to
understand actual observed power for the analyses conducted within this hypothesis.
Again, actual observed effect size (d = 1.01), alpha (0.05), sample size (n = 33), number
of groups (two), and number of dependent variables (two) were entered into the
application which provided the actual power parameter of 0.98 (strong). Thus, power
was not an issue related to appropriately testing this hypothesis.

Hypothesis 3
Individuals with SCD and no history of stroke will danonstrate greater cognitive
fatigue when compared to healthy participants, as measured by the changes in hit rate and
reaction time over the course of the CPT-11, a sustained attention continuous performance
measure.
A power analysis was conducted for a medium effect size for a mixed betweenwithin group ANOVAs (repeated measure: lSthalf of CPT vs. 2ndhalf of CPT). Results
indicated that 34 participants were needed for the current study.
Post-hoc power analysis was conducted to understand actual observed power,
with observed effect size (d = 0.10), alpha (0.05), sample size (n = 33), number of groups
(two), and number of repetitions (two) entered into the application which provided the
actual power parameter of 0.06 (weak). As expected, given that multiple parameters
were involved in this analysis (e.g., group and time), future studies might consider
collecting a greater number of participants should inferences related to both groups and
elements of the tests to be desired.
Power analyses were conducted in order to determine which of the following
statistical analyses required the highest number of participants. Results of power analyses
indicated that 42 participants were needed in order to conduct a MANOVA,
MANCOVA, and matched pairs t-test consistent with hypotheses HI,
H2, and H3
(Erdfelder, Fad & Buchner, 1996). However, there were recruitment challenges that
allowed for the collection of 28 participants. Notably, post-hoc observed power analysis
indicated that the two primary study hypotheses (I and 11) were not impacted by the
number of participants available for analysis. It may be postulated that Hypothesis I11

would have benefited from additional participants, due to the actual power observed,
which was weak. Despite minimal variability for CPT-I1 scores between groups, the
pattern of scores suggests that a trend may have been observed with the addition of
participants.

s-ary

The purpose of this chapter has been to discuss the methodology which was used
in the current study. The population of interest and method of sampling were reviewed.
The methodology for determining the sample size needed for the current study was
included. Data collections methods, the assessment battery, and the reliability and
validity for each of the measures were discussed. Considerations and limitations were
included for all of the instruments. Lastly, the study design, and each hypothesis test with
the appropriate statistical analysis for each hypothesis was presented. Limitations of
group differences given the lack of matched control group must be considered in
interpreting the results.

CHAPTER IV
Results
Prior to conducting inferential analyses to test the study hypotheses, descriptive
statistics were calculated. Table 3 presents intercorrelations for all of the primary study
variables. As observed in the Table 3, a number of variables share variance, suggesting
that the constructs assessed measure common factors. Notably, parent income, a proxy
for socioeconomic status and factor ofien associated with performance on cognitive
instruments, was related significantly with education (expected), working memory,
processing speed, and CPT performance. The absolute correlations values indicated that
income explained 34% of the variance in education, 15% of variance in processing speed,
26% of variance in working memory, and 23% variance in CPT hits. Intercorrelation
results should be interpreted with caution given the possibility for Type I error occurring
secondary to the multiple repeated correlation analyses (i.e., Family-wise error rate)
conducted with this approach.

Table 3

Table of Intercorrelations for Study Variables
1
1. Age
2. Parent Income
3. Parent Education
4. Lifetime Hospitalizations
5. Processing Speed Index
6. Working Memory Index
7. CPT # Hits 1st Half

8. CPT #Hits 2nd Half

2

3

9

10

0.22

0.00

0.34

0.21

0.14

1.00 -0.37 0.50* 0.44* 0.56* 0.35*

0.02

0.02

1.00 0.16 0.26

4

5

0.20

0.22

1.00 0.58* -0.23

1.00

6

7

8

0.35* 0.54* 0.39*

0.39* OSl* 0.48*

-0.68

-0,25

1.00

0.46* 0.41*
1.00

-0.11

-0.05 0.40* 0.35*
0.23

0.49* 0.41*
1.00

-0.22 -0.37*
0.02

-0.04

0.89*

0.08

-0.12

1.00

0.12

-0.11

1.00

0.90*

9. CPT Hit Rate (ms)1st
Half
10. CPT Hit Rate (rns) 2nd
Half
Note. *p < 0.05

1.oo

Table 4 presents descriptive values aggregated by study group, respectively. With
regard to descriptive statistics related to the study measures, healthy controls performed
better on all indices assessed and significantlybetter on the processing speed index (PSI;
p < 0.001) and working memory indices (WMI;p = 0.03).

Table 4
Descriptive Statistics for the Sample Aggregated by Group (n = 33)

Control (n = 19)

SCD(n= 14)

Total (N = 33)

PSI
WMI
CPT
Hits Half 1
Hits Half 2
Hit Rate (ms) Half 1
Hit Rate (ms) Half 2
Note. PSI = Processing Speed Index; WMI = Working Memory Index; CPT = Continuous

Performance Test. P-values based on one-way analysis of variance with SCD entered as
independent variable to compare study group means.

Again, it must be emphasized that there was a lack of an appropriate matched
control group in this study, and therefore group differences need to be interpreted with
caution. While studies are limited with respect to specific cognitive functions among
different raciaUethnic backgrounds, the findings that emerged in this literature and
included variables such as those utilized in this study, namely working memory and

processing speed, are inconsistent. Moreover, these measures have been considered by
some as culturally unequivalent across groups (Manly, 2005).

Hypotheses Tested
The following information shall summarize each of the study hypotheses,
inferential analyses implemented to test the hypotheses, and the results obtained. Results
must be considered within the context of the limitations of the control group discussed.

Hypothesis I
In this initial hypothesis, it was expected that children with SCD and no known
history of strokes would have significantly greater deficits in processing speed and
working memory than the healthy controls. This hypothesis was tested using a one-way
multivariate analysis of variance (MANOVA) with group (SCDIno stroke vs. healthy)
entered as the independent variable and WRAML-2 Working Memory Index and WISCIVIWAIS-I11Processing Speed Index entered as the dependent variables.
The results provide support for this hypothesis. Specifically, the omnibus
multivariate analysis, using the Wilks' Lambda procedure, indicated significant group
~
differences for the combined PSI and WMI dependent variable, F (2,32) = 1 0 . 9 , <
0.001, power = 0.98, partial eta2 = 0.42). Subsequent tests for group difference were
conducted independently for each of the two dependent variables using the analysis of
variance (ANOVA) procedure. The results indicate that for both the PSI, F (1,31) =
21.7,~
< 0.001, power = 0.99, partial eta2 = 0.41, and for the WMI, F (1,31) = 5 . 3 , =
~
0.03, power = 0.60, partial eta2= 0.15, the healthy group significantly outperformed the

SCD group. Specifically, on the PSI, the healthy group obtained a mean result of 109.6
(SD = 11.7) compared to the SCD mean of 88.6 (SD = 14.3) and on the WMI the healthy

group produced a mean score of 100.9 (SD = 13.2) compared to a SCD mean score of
90.4 (SD = 12.8). Table 5 provides the ANOVA source table for these findings and
Table 4 provides group means for comparison.

Table 5
ANOVA Source Valuesfor Hypothesis I (n = 33)

Source

SS

Df

MS

F

P

Intercept
PSI
WMI
Group
PSI
WMI
Error
PSI
WMI
Total
PSI
WMI
Note. PSI = Processing Speed Index;WMI = Working Memory Index. Group provides for SCD

vs. healthy.

Hypothesis 2
In the second hypothesis it was expected that, similar to hypothesis 1, children
with SCD would produce lower scores on the Processing Speed index of the WISCIVIWAIS-111and Working Memory indices of the WRAML-2 compared to healthy
children; however, in this hypothesis the effect of age was controlled. Thus, the outcome
postulated in Hypothesis I was again expected, however, in this hypothesis there was
expected to be a significant effect of age within the overall multivariate model.
This hypothesis was tested using a one-way multivariate analysis of covariance
(MANCOVA) with group (SCDIno stroke vs. healthy) entered as the independent
variable, the Processing Speed and Working Memory indices entered as the dependent
variables, and age entered as the dependent covariate.
The results provide mixed support for this hypothesis. Specifically, the omnibus
MANCOVA analysis using the Wilks' Lambda procedure was again statistically
~ 0.001, power = 0.99, partial eta2 = 0.44),
significant for group, F (2,29) = 1 1 . 3 , <
however, the multivariate analysis for the age covariate was not significant, F (2,29) =
2.6, p = 0.09, power = 0.48, partial eta2 = 0.15). Thus, simultaneous consideration of all
variables within the multivariate analysis indicated that there are differences between
SCD and healthy participants, with limited impact of age on this relationship.
Inspection of the univariate analyses revealed, similar to hypothesis I, significant
group differences between SCD and healthy participants for both the PSI, F (1,30) = 21.8,
p < 0.001, power = 0.99, partial eta2 = 0.42, and the WMI, F ( 1 , 30) = 5 . 5 , ~< 0.03, power
= 0.61,

partial eta2 = 0.15 indices. Notably, however, in the univariate analyses the age

= 0.04, power =
covariate achieved statistical significance for the WMI, F (1, 30) = 4 . 4 , ~

0.53, partial eta2 = 0.13, but not for the PSI index, F (1,30) = 2.1 , p = 0.16, power = 0.29,

partial eta2 = 0.06. Thus, these results indicate significant group differences on the PSI
and WMI indices between SCD and healthy controls; however, age was a significant
factor only for the WMI. These findings are summarized in Table 6.
As a further inspection of this hypothesis, a Pearson bivariate correlation was
conducted to understand the simple linear relationship between WMI, PSI, and age. As
~ 0.21,
expected, the relationship between age and PSI was not significant, r = 0 . 2 3 , =

however, there was a statistically significant, positive relationship between age and WMI,
r =0 . 3 5 ,=
~ 0.047, indicating that, across groups, WMI scores improved with age in this

sample.

Table 6

ANOVA Source Valuesfor Hypothesis II, Age as Covariate (n
Source

SS

Df

MS

F

= 33)

P

Intercept
PSI
WMI
Age
PSI
WMI
Group
PSI
WMI
Error
PSI
WMI
Total
PSI
WMI

Note. Age = covariate. PSI = Processing Speed Index; WMI = Working Memory Index.
Group provides for SCD vs. healthy.

Hypothesis 3
In this third hypothesis, it was expected that individuals with SCD and no history
of stroke would demonstrate greater cognitive fatigue when compared to healthy
participants, as measured by the CPT-11. In order to test this hypothesis, performance
from the first and second half of the CPT-I1 was subtracted to obtain a difference score
for both the SCD and healthy control groups. An ANOVA was employed to examine
mean differences between groups, with the expectation that differences would be greater
in the SCD group (i.e., indicating a worsening of performance) than in the healthy control
group.
The results indicated that difference scores did not vary for number of hits from
the first half to the second half of the CPT between healthy control (M = 0.84, SD = 2.99)
and SCD participants (M = 0.71, SD = 3.60), F (1,31)

=0.01,~
= 0.91.

Similarly, the hit

rate difference scores also did not vary between healthy control (M = 20.7, SD = 83.7)
and SCD participants (M= -25.1, SD = 86.0), F(1, 31) = 2 . 4 0 , ~= 0.14. Thus, the
degree of change between the first and second halves of the CPT did not vary as a
function of study group.
In order to firther explore this hypothesis, mixed between-within group ANOVAs
were employed to simultaneously examine the impact of group (SCD vs. healthy) and
time (repeated measure: 1 half of CPT vs. 2* half of CPT) on both the hit and hit rate
parameters of the CPT. Table 7 provides non-modeled means and standard deviations,
aggregated by group and time, for these comparisons. With regard to number of hits,
there was no main effect for time, F ( l , 3 1) = 1.85,p = 0.18, power = 0.26, partial etaZ=
0.06, no main effect for group, F(l,31) = 1 . 5 7 , =
~ 0.22, power = 0.23, partial eta2=

0.05, and the group x time interaction term was not found to be significant, F ( l , 3 1 ) =
0.12, p

= 0.91,

power = 0.05, partial eta2 = 0.00. Similarly, with regard to the hit rate,

there was no main effect for time, F ( I , 3 1 ) = 0.21, p

= 0.89,

power = 0.52, partial eta2=

0.001, no main effect for group, F ( l , 3 1 ) = 1 . 8 8 , ~= 0.18, power = 0.26, partial eta2=
0.06, and the group x time interaction term was not found to be significant, F (1,3 1 ) =
2 . 4 0 , ~= 0.14, power = 0.32, partial etaZ= 0.07. Figure 2 depicts the pattern of these
relationships. Given the outcomes of these analyses there has been no empirical support
in this study for Hypothesis 111, which would be expected given that visual inspection of
the mean performance scores suggests minimal variability for CPT scores between
groups.

Table 7

Descriptive Statistics for CPTPerformance Aggregated by Group (n
Control (n = 19)
M

SCD (n = 14)

SD

M

SD

Hits Half 1

159.47

3.26

157.21

4.76

Hits Half 2

158.63

5.47

156.50

7.20

Hit Rate (ms) Half 1

1076.89 184.66

1140.71 212.73

Hit Rate (ms)Half 2

1056.16 152.38

1165.79 195.21

Note. CPT = Continuous Performance Test.

= 33)

Number of Hits

1st Half

2nd Half
CPT Half

Hit Rate

SCD

1000.0
1st Half

2nd Half
CPT Half

Figure 2. CPT Performance by Half

Clinical Group
Within the group of participants with sickle cell disease, significant and clinically
relevant findings emerged. The sickle cell group consisted of 14 participants ranging in
age from ten to twenty-two. As noted above, 3 patients were between ages 10 and 1 1
years, 8 patients were between 13 and 17 years, and 3 were between ages eighteen and
twenty-two. Parents had a mean of 13.1 years of education, ranging from 10 years to 16
years of education. Median parental income was $30k, well below the median household
income for the state of residency. One participantlparent did not report income.
With regard to racelethnicity, 9 patients were African Americans, 4 were
Hispanic, and 1 was Caribbean. Gender was well distributed, with 8 males and 6 females.
Patients reported a mean of 35.1 hospitalizations, with numbers ranging as low as 5 up to
as many as 100 in their lifetime.
On the WISC-IV and WAIS-111, mean performance for the Processing Speed
Index was a Standard Score of 88.57, which is lower than average when compared to the
normative population. Individuals with SCD yielded scores on the PSI ranging from 59 to
121 standard scores. Specifically, 1 participant's score fell in the Extremely Low range, 2
in the Borderline range, 5 in the Low Average, 5 in the Average range, and 1 in the
Superior range.
On the WRAML-2, participants fiom the SCD group yielded scores on the
Working Memory Index ranging from standard scores of 68 to 108 with 90.43
representing the mean score. Specifically, 1 participant performed in the Extremely Low
range, 2 in the Borderline range, 5 in the Low Average range, and 6 in the Average range.

On the CPT-11, participants with SCD performed similarly with regard to the
number of hits they made in the first and second half. In terms of hit rate, how quickly
each person responded, mean scores increased in the second half as expected, fiom a
mean score of 1056 ms to 1165 ms, indicating that participants with SCD may have
responded slightly slower in the second half; however, differences were not significant
enough to reach statistical significance.
Overall, these findings reveal important findings for children and adolescents with
no known history of stroke. The current study demonstrates that patients with sickle cell
disease remain at risk for lower scores, particularly on measures of processing speed,
when compared to the normative population.
Given that the majority of patients had the most severe type of sickle cell disease,
it is possible that the level of anemia may have contributed to the findings within this
group. Future studies should examine hematocrit and anemia levels within a sickle cell
population who has not had any type of neurological insult.

CHAPTER V
Discussion
As previously discussed, SCD is a serious chronic health condition as it places
individuals at risk for many problems including, but not limited to, pain and vasoocclusions such as overt or silent strokes or infarcts. The disease and its impact on
cognitive and academic functioning can be best understood from a biopsychosocial
developmental model because of the significant number of biological, cultural, socialemotional, developmental, and contextual factors that impact these children (Armstrong,
2006; Gustafson et al., 2006). Thus, the current study considered several of these
components throughout the study, including age, type of SCD, stroke, SES, level of pain,
and possible cumulative effects on the brain and in analysis of the data. Specifically,
only individuals with SCD types SS and SC and no evidence of stroke were included in
this study.
Summary and Conclusions of Research
Neuropsychological findings have frequently established that children with SCD
who had CVAs are at risk for cognitive declines (Armstrong et al., 1996; Brown et al.,
2000). To date, the majority of studies have focused on global impairments in children
and adolescents with SCD (Steen et al., 2005; Swift et al., 1989; Wang et a]., 2001). Yet,
Schatz and colleagues (2002) contend that measures of specific cognitive abilities are
more sensitive than IQ scores when determining functioning in children and adolescents

with SCD. In addition, the studies that incorporated radiographic findings have often
identified cognitive deficits associated with frontal lobe involvement in terms of attention
and executive functioning (Armstrong et al., 1996; Berkelhamrner, Williamson, Sanford,
Dirksen, Sharp, & Margulies, 2007; Brown et al., 1993). Neuropsychological measures
are also considered useful tools in helping predict localization of strokes (Debaun,
Schatz, Siege], Koby, Craft, & Resar, 1998). However, very few studies have examined
specific executive functions among individuals with SCD and no evidence of CVAs
(Gold eta]., 2008).
The present study examined the relationship between children and adolescents
with SCD compared to their healthy peers according to specific cognitive functions. SCD
has been associated with global deficits, particularly among those with have experienced
CVAs. Recently, it has been suggested that children with SCD and no detectable strokes
may also experience cognitive difficulties; however, this finding remains irresolute
(Brown et al., 2000; Gold et al., 2008; Noll et al., 2001). Researchers are beginning to
examine a possible age-related decrement in children and adolescents, suggesting that
perhaps as children develop and age, they have more difficulty due to the effects of SCD
on their brain functioning (Brown et al., 1993; Fowler et al., 1988; Kral et al., 2003;
Steen et al., 2005; Wang et al., 2001). The findings generally indicate a possible decline
over time; however, there are many inconsistencies across the neurocognitive domains
that have been assessed and the measures used to examine performance.
Cognitive fatigue is an important construct, yet most of the literature on cognitive
fatigue has focused on subjective measures. Moreover, the researchers that have assessed
objective measures of fatigue have been focused on conditions that tend to develop in

adult stages of development. The current study is the first to incorporate an objective
measure of fatigue with a sample of children.
The current study was devised to provide a better understanding of specific
cognitive functions among individuals with SCD and no evidence of any type of
cerebrovascular event. As discussed in Chapter IV, findings with regard to cognitive
deficits in children with SCD and no evidence of stroke are mixed. This Chapter will
review the results of each hypothesis tested, which overall, revealed significant
differences between groups for specific executive functions but not for cognitive fatigue.
Lastly, implications for future research and suggestions for practice will be reviewed.
Despite attempts at matching controls, there were significant differences between
the two groups according to race and SES which limits the interpretation of group
differences. Due to the lack of a comparable control group, findings may be spurious and
the statistical differences found may not accurately reflect what truly explains the
differences revealed in the study. Moreover, intercorrelations found that parent income
was associated with working memory and processing speed. Therefore, caution must be
given when considering any between group differences, as parent income and race likely
contributed to between group differences.

Hypothesis I

The initial hypothesis sought to determine if there were differences in children
and adolescents with SCD and no evidence of stroke compared to healthy controls with
regard to their performances on the Processing Speed Index of the WISC-IVtWAIS 111
and the Working Memory Index of the WRAML-2. This question was prompted by the

extensive literature on global deficits (Steen et a]., 2005; Swift et al., 1989; Wang et al.,
2001). There remains a dearth of literature on specific executive functions despite a few
studies that have reported lower performance on memory and attention tasks when
compared to healthy children (Brown et al., 1993; Fowler et al., 1988; Ris & Grueneich,
2000). In addition, the majority of studies incorporated children with SCD and CNS
abnormalities, and did not include individuals with SCD without cerebral events
(Armstrong et al., 1996; Brandling-Bennett et al., 2003; Schatz & Roberts, 2005; White,
et al., 2000). Of those that examined SCD in the absence of stroke, outcomes are varied
(Bernaudin et a]., 2000; Brown et a]., 2000; Brown et a]., 1993; Fowler et al., 1988; Gold
et a]., 2008; No11 et a]., 2001). Thus, the current study is quite unique in its evaluation of
children and adolescents with SCD and no evidence of stroke.
As expected, the group of children and adolescents with SCD and no evidence of
stroke performed significantly lower on working memory tasks and processing speed
tasks than the control group. This finding is consistent with a more recent study that also
found significant differences between children with SCD and no evidence of CVA in
comparison to the normative population (Gold et al., 2008). However, since these groups
were not matched for SES and race, it is quite possible that the differences in working
memory and processing speed relate to the significant discrepancies between groups,
such as race or SES.
Several possible explanations may have accounted for some of differences, aside
fiom the limitations between the participant and control groups discussed. First, unlike
many previous studies, the current study only included the most severe types of SCD: Hb
SS and HbSC. In an analysis by Steen and colleagues (1999) individuals with HbSS,

those with lowest levels of hematocrit, demonstrated greater cognitive impairments in all
cognitive domains, except for processing speed. In a later study by Steen and colleagues
(2005) individuals with lower levels of hematocrit and cognitive impairments as
measured by MRIs demonstrated greater impairments on several subtests on the WISC111, including several verbal and performance tasks. However, there were no impairments
on measures of processing speed. On the contrary, Bernaudin and colleagues (1999)
found that processing speed and working memory were both significantly lower in
severely anemic patients, indicating that hematocrit contributes to both processing speed
and working memory deficits. Therefore, hematocrit levels may have been a factor in the
current finding; however, since hematocrit levels were not included, therefore, this is
merely speculation.
Second, although all charts were reviewed for history of CVAs, not every chart
included an updated MRI. Therefore, it is possible that a number of these children may
have experienced a silent stroke, in which a child could have been asymptomatic.
Moreover, previous findings suggest that the majority of silent strokes occur in the frontal
lobes, the location predominantly responsibility for processing speed and working
memory tasks (Debaun et al., 1998). Other researchers have theorized that physiological
changes, such as hypoxic events, that would not be depicted on standard imaging could
be responsible for cognitive effects in children with SCD without stroke (Schatz et al.,
2002). Finally, the etiology of cognitive deficits in children with SCD is not fully
understood and remains a relatively new focus in the field of neuropsychology (Steen et
al., 2005). Although researchers have generally agreed that the disease itself is likely to
have the greatest impact on cognitive functioning (Berkelhammer et al. 2007), others

have found evidence for greater risks depending on the severity of socioenvironmental
risk factors coupled with anemia severity (Schatz, Finke, Roberts, & Roberts, 2004).
Therefore, it is highly recommended that ongoing research be conducted with medical
doctors in conjunction with neuropsychologists in order to better explain the relationship
between anemia and cognitive functioning.

Hypothesis 2

The second hypothesis posited that, once again, children and adolescents with
SCD would score lower on the Processing Speed and Working Memory indices when
compared to healthy children and adolescents and that there would be a significant effect
of age. This question was formulated, in part, based on previous research that found older
children with SCD perform more poorly than younger children on some cognitive
measures. However, most of the earlier studies focused on a limited age range. As
suggested in previous research by Schatz and colleagues (2002), the age range of the
current study included individuals ages 10 to 22, with a relatively fair distribution, in
order to account for younger children, adolescents, and young adults.
The findings on an age-related decrement on specific cognitive measures have
been variable. For example, as previously discussed, Steen and colleagues (2005) found
that performance on the WISC-I11 Full Scale IQ decreased with age. Brown and
colleagues (1993) only found that visual-motor scores decreased with age. Fowler and
colleagues (1 998) demonstrated that older children performed more poorly on reading,
visual-motor, and attention tasks when compared to younger children. In the study
conducted by Wang and colleagues (2000), children with SCD and no MRI abnormalities

performed worse over time on measures of verbal intellectual functioning and
mathematics fiom the Woodcock Johnson Test of Academic Achievement. Kral and
colleagues (2003) found significant results supporting an age-related decrement on
measures of intellectual functioning, sustained attention, and executive functioning;
however, their study failed to differentiate the SCD groups according to level of severity
when examining the impact of age.
Still others (Swift et al., 1989) did not find any evidence for an age-related
decrement (Wasserman et al., 1991). Furthermore, one study found that younger children
performed lower than older children on visual, verbal, and memory tasks.
The results of hypothesis I1 revealed that, once again, there were significant
differences between both groups; however, contrary to expectation, the covariate age was
only a significant factor for working memory in the overall analysis.
Further inspection revealed an unexpected finding. The original hypothesis was
developed under the assumption that age would be a significant factor and that there
would be a negative relationship between age and index scores for both working memory
and processing speed tasks. Age was not significantly related to processing speed. In fact,
working memory was found to have a positive relationship with age, indicating that for
both groups, working memory scores improve with age.
Although these findings are not consistent with the literature previously discussed
that supports an age-related decrement, several factors should be considered. First, of the
studies that have found an age-related decrement, the intellectual and cognitive domains
utilized in the study were quite variable. These domains included intellectual components
such as Full Scale IQ, Verbal IQ, cognitive domains such as visual-motor skills, visual

working memory, attention and executive functioning skills, as well as academic domains
of reading. Given these inconsistencies across studies, it is not unexpected that the
results were not readily generalizable to the current study. Toward this end, Schatz and
colleagues (2002) contend that the measures most apt at assessing cognition in children
with SCD without cerebral infarctions have not been established.
As previously discussed, the current study focused specifically on Processing
Speed Index of the WISC-IV and WAIS-111, and the Working Memory Index of the
WRAML-2. To date, no studies have found an age-related decrement with either of these
indices. In fact, those studies that found significance for working memory utilized the
Freedom from Distractibility Index from the Wechsler Scales of Intelligence, generally
an outdated version, such as the WISC-R or WISC-I11 (Wang et al., 2001).
Another issue of generalizability relates to the sample. That is, only some of
previous studies that established an age-related decrement examined children with SCD
and no evidence of CVAs. Some researchers failed to delineate between children with
SCD and no evidence of infarction and SCD with silent or overt stroke when examining
the relationship between age and cognition (Kral et al., 2003).
As a final point, it is necessary to consider possible confounding variables that
may have impacted the results. One such explanation that may have contributed to the
improvement of working memory scores with age is related to psychosocial adjustment
of the disease and possible maturation. Maturation can results from changes that occur
within participants and often interfere with treatment (Pedhazur & Schmelkin, 1991). The
possibility exists that younger children with SCD are not as adjusted or familiar to the
effects of the disease itself, such as pain crises, while older children may be better

adjusted. Toward this end, older children with SCD may have learned to develop or
compensate for cognitive weaknesses, such as working memory difficulties, which may
have impacted their performance on the working memory tasks. Although this may have
contributed to the positive relationship between age and performance on the Working
Memory Index, a similar relationship would have been expected with the Processing
Speed Index.

Hypothesis 3

The third hypothesis postulated in this study sought to explore whether
individuals with SCD would perform more poorly than healthy controls on the CPT-11.
As noted earlier, to date, no studies have examined cognitive fatigue as measured by
performance during a sustained mental task with a Sickle Cell population, despite
physiological factors that certain aspects of the disease, such as low hemoglobin,
manifest itself by fatigue (U.S. Department of Health and Human Services, 2002).
In light of empirical research on cognitive fatigue and the evidence for fatigue
among individuals with SCD, it was expected that performance for the SCD group would
diminish in second half of the CPT-I1 due to cognitive fatigue. Contrary to this
expectation, no difference was established for either measure employed, neither hit rate,
nor reaction time.
A possible explanation for this finding may be related to the sample population
differences, as the majority of studies that have examined objective forms of cognitive
fatigue have been conducted with adults and medical conditions such as MS, TBIs, and
chronic fatigue syndrome (DeLuca, 2005). In addition, the declines in performance found

across sustained attention measures were generally with adult populations, which would
not directly generalize to a pediatric population.
With regard to instrumentation, the sustained attention task generally employed
when measuring objective cognitive fatigue was the PASAT. The PASAT precluded
utilization of this assessment tool in the current study with a pediatric sample, as its
norms were developed on individuals ages 16 and up. Instead, a more suitable instrument
which assesses a similar construct, sustained mental effort, and has similar variables,
such as reaction time and hit rate, the CPT-11, was selected. Thus, instrumentation in the
current study may have contributed to the lack of significance between the SCD group
and the control group.
Given the threats of instrumentation, that this was the first study to examine an
objective form of cognitive fatigue using the CPT-I1 and the first to implement a
methodology based on Deluca's (2005), coupled with the selection of the sample
population, it is not unusual that the outcome was not significant. Of note, as evidenced
in Figure 1, the trend of Hit Rate as measured by milliseconds in the SCD group was in
the direction of slowed reaction time in the second half of the test as compared to the
control group, as predicted. Although the difference between the variability between the
two groups did not reach statistical significance, there was a suggestion of a relationship
in the expected direction, which is similar to results found in children with other
neurological diagnoses (Fleck, Shear, & Strakowski, 2002) who demonstrated processing
speed and vigilance difficulties despite not reaching statistical significance. However, the
effect size was too small to support the proposed hypothesis. Fleck and colleagues have
noted that the variability measures of the CPT-I1 are at times insensitive to these

differences due to the ceiling level of hit rates and reaction time. In addition, the use of
counterbalancing of measures for a study that lasted only about one hour, may have
actually diminished the nuanced differences in fatigue. Given that one of the measures
was assessing cognitive fatigue, the CPT-I1 probably should have been given consistently
as the last measure in order to assess potential cumulative effects of the testing
consistently across each session. Controlling for test administration sequence of the CPTI1 may have better captured the level of fatigue across each participant.

Limitations
The outcomes of this study revealed several significant findings as well as
implications for various children and adolescents with sickle cell disease. Despite these
findings, the results must be interpreted within the limitations of the study design. The
greatest limitation and an inherent threat to the validity of the study is the difference
between the SCD group and the control group according to race and SES; therefore, any
significant differences between groups may be spurious. Although several attempts were
made to match patients with controls according to similar demographic information with
success across age, gender, and parent education, there is a serious flaw in the disparity
between the SCD group and the control group. For example, the control group reported a
greater parental income compared to the SCD group. This finding is directly in line with
the literature that reports that the majority of children with SCD belong to families with
low incomes, often at or below the poverty line, which has been found to cause
significant limitations in the quality of healthcare as well as challenges in a child's social
and academic success (Schatz & McClellan, 2006). As discussed and has been found in

numerous studies (Sattler, 2008), significant disparities remain between groups of
different racelethnicity, SES, and educational background. In addition, Ryan and
colleagues (2005) found that the educational opportunities were more robust than
raciallethnic backgrounds alone in explaining neuropsychological performance
differences between these groups. Due to the many influences of racelethnicity, SES, and
quality of education on cognitive measures, Manly (2005) suggests a number of
possibilities to address these discrepancies in clinical work and research, such as
developing alternative approaches to establishing normative data that adequately captures
true cognitive abilities. In addition, the limited number of studies on large minority
groups with measures such as with the WRAML-2, makes it difficult to extrapolate the
meaning of the differences found in the current study. Therefore, neuropsychological
differences between African Americans and unmatched groups should be merely
speculative as failing to do so may result in erroneous interpretations of the differences
found.
Schatz and McClellan (2006) suggested that the interaction between SES and
disease severity as measured by type of anemia (HbSS or HbSC), could impact cognitive
abilities. Thus, a limitation in the current study is that, despite significant efforts to
control for biological and social factors that could potentially impact cognitive
functioning, it did not evaluate potential interactions between disease effects and socialenvironmental risk factors beyond age. Since SES and anemia severity were not
controlled for in the analysis, it is quite possible that these factors may have influenced
the lower scores on the Working Memory and Processing Speed Indices.

Another significant limitation was the sample size. Several factors were
responsible for the size of the sample. Only one treatment center was utilized in the
current study, which reduced the opporlunity to collaborate clinical samples across
multiple clinical settings. Although the size of the sample was adequate in order to
provide sufficient power and effect size, the possibility remains that the small sample size
may have mitigated power and diminished effects for the covariate on processing speed
in the second or third hypotheses, that otherwise would have been detected with a larger
sample. The likelihood of detecting an effect for hypotheses 3 is not as great of an issue
as the variance was so low in this particular analysis.
With regard to the sample, the heterogeneity of race is a considerable limitation
and the result of the recruitment process. Controls were given solicitation letters through
various methods of recmitment, such as family and friends of patients and
undergraduates at an urban university. Since there was no screening process developed,
when potential controls called to schedule an appointment with me, there was no way to
ensure that the individual was matched for racelethnicity with the patient sample.
Therefore, many of the individuals that agreed to participate were of Caucasian
background. Similarly, the control group was disproportionate with regard to gender.
That is, a higher number of females was represented in this group.
In terms of selection of patients, charts were reviewed for documentation of any
type of CVA which included neuroimaging studies, when identifying patients who met
criteria for the study, SCD type Hb SS or Hb SC without any evidence of stroke.
Although the participants were carefully selected and believed to have no vasoocclusions, there was no way to control for the possibility of a cerebral vascular event,

namely a silent stroke, since the most recent imaging available at the time of the chart
review.
As discussed in Chapter I, a significant limitation in quasi-experimental designs is
that the design lacks random assignment, and therefore, true manipulation of treatment
variables is not possible. In the absence of randomization, conclusions about casual
relationships cannot fully be established. Instead, generalizations about the findings can
be made.
Finally, the use of the CPT-I1 poses a limitation with regard to instrumentation.
As previously discussed, no known studies have investigated an objective measures of
cognitive fatigue with a sickle cell population. Although the CPT-I1 meets the criteria for
examining performance on a sustained attention task, as measured by hit rate (number
correct) and reaction time, there is no empirical evidence to support this is a reliable tool
for assessing cognitive fatigue.
Notwithstanding these limitations, the data supports the body of literature of
emerging evidence of specific neurocognitive deficits in children and adolescents with
sickle cell disease and no evidence of stoke. Toward this end, the findings highlight the
importance of using executive functioning measures, including working memory and
processing speed, in order to gauge current functioning and educational or treatment
needs.

Suggestions for Future Research and Practice
Future studies should continue to explore the differences in specific
neurocognitive functions in children with SCD and no evidence of structural brain
abnormalities, including silent infarcts. In addition, it is important to identify the
measures that are sensitive to specific neurocognitive deficits and to replicate these
findings using similar tools. As noted earlier, the variability across studies with regard to
types of measures used when examining working memory, for example, is quite high.
Finding a few measures that tap into cognitive deficits will help provide consistency not
only in research but in practice. In addition, specific cognitive abilities have been
empirically validated as having more sensitivity to cognitive effects than IQ measures.
When feasible, corroboration of neuroimaging studies and transcranial Doppler
findings with data collection would help to control for the influence of silent strokes on
cognitive functioning. Without certainty that individuals with silent strokes are excluded
ffom a study places a significant limitation on the research, and may contribute to some
of the cognitive decline. Toward this end, Moser and colleagues (1996) established that
even in the absence of an overt stroke, MRI can detect infarction and ischemic disease.
In addition, the impact of MRI versus neurological history, such as in the current study,
has not been evaluated empirically (Schatz et al., 2002). Further exploration is needed to
establish whether neurological history without MRIs is sufficient for controlling for silent
strokes. Until then, this remains an unresolved issue.
Neuroimaging findings are not the only factors which can impact demonstrate and
possibly identify cognitive deficits. Specifically, hematocrit has been considered a risk

factor (Bernaudin et al., 2000). Future studies should evaluate the factors related to
declines.

In terms of the age-related decrement, prospective studies need to better examine
the relationship between age and cognitive functioning by utilizing a control group and
similar measures, since the exact relationship remains unknown. Ideally, the age range
should include preschool children though school age and even young adults. Further,
longitudinal studies would likely be the best methodological design in order to refine the
understanding and impact of SCD as having cumulative effects on the brain, as many
studies, including the current study, purported to measure.
With regard to cognitive fatigue, other studies are needed to establish validity on
an objective measure of mental fatigue with pediatric populations. Given that cognitive
fatigue has been well-established in adults with chronic illnesses, it is quite possible that
a disease that manifests itself with similar symptomatology, chronic pain and fatigue, will
also cause mental fatigue.
Although beyond the scope of the current study, very few studies have evaluated
the contribution of direct and indirect causes of cognition in children with SCD. For
example, studies have identified the significance of biological factors including
hematocrit and silent infarcts, and psychosocial factors such as low SES; however,
minimal studies have evaluated the relative contribution of all causes of cognitive
outcomes. Larger scale studies across multiple sites and including multiple groups,
including controls, silent strokes, and overt strokes as well as separating types of anemia
(e.g., Hb SS, Hb SC) would afford researchers the opportunity to measure such outcomes.

These suggestions will help identify the cognitive functions that are most
impacted by the disease itself as well as indirect factors, and have important implications
for practice. Specifically, baseline assessments at an earlier age as well as routine
screenings could help monitor the progress of children and adolescents with SCD and
identify educational needs. Ultimately, the goal is have a sound methodology so that
neuropsychologists can evaluate and identify neurocognitive weaknesses.
The current study yields important findings for psychologists. Specifically, it
raises an important issue with regard to the many struggles that minority groups with
chronic illness experience, including economic disadvantages. Psychologists need to be
sensitive to the many issues that this group is susceptible to, particularly when working
with children and adolescents in a therapeutic manner. Moreover, there is a social justice
issue that calls for the attention of psychologists in order to better service this population.
More funds and grants are needed to expand the number of studies on SCD and to
provide more comprehensive neuropsychological evaluations that are often expensive to
conduct.
The most significant outcome of the current study is the finding that children and
adolescents without any known history of a stroke are at risk for cognitive deficits.
Neuropsychologists should therefore conduct assessments as early as possible with all
children and adolescents; since a true baseline evaluation would be impossible as this is
disorder that a child is born with, it is strongly recommended that all children with sickle
cell disease have a neuropsychological evaluation when they enter elementary school
(i.e., kindergarten or first grade). Assessment at this early age would gauge the child's

abilities before the educational and executive functioning demands begin to increase and
would allow for tracking the learning trajectory of the child.

Conclusion
In conclusion, the results of the current study suggest that specific cognitive
measures remain appropriate for identifylng cognitive weaknesses in a SCD sample.
There are indications that SCD has an impact on the frontal lobes of the brain, even in
children with SCD and no stroke. The results fell short in identifylng an age-related
decrement for processing speed and working memory in a SCD population; however,
further investigation is warranted as cross-sectional designs are limited in evaluating
cumulative effects on the brain.
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Appendix A
Solicitation Letters

Dear Patient or Parent,

I am inviting you to participate (or to permit your child to participate, if he or she is under 18
years of age) in a research study that will examine children and adolescents across several areas
of functioning. You have been asked to take part in this study because you have Sickle Cell
Disease.
The study is being conducted by Laura J. Tagliareni, M.A., a doctoral student in the Counseling
Psychology Program at Seton Hall University, South Orange, New Jersey and an employee at the
medical center where the study is taking place.
The purpose of the study is (1) to see how quickly children are able to complete tasks and how
they remember new information (2) to see if older adolescents complete tasks slower than their
younger peers (3) to see if older adolescents have more difficulty remembering new information
than their younger peers (4) to see if some children and adolescents tire more quickly at tests than
others. Estimated time of participation is 1 hour.
Patients 18 years and older or parents interested in having their child participate in this study
should contact Laura Tagliareni at 201-996-5332 to schedule an appointment to complete the
research battery at the medical center. Once the appointment is scheduled, Ms. Tagliareni will
meet with you to complete a form that you will sign only if you decide that you want to do the
study. A research assistant will then begin the study with you.
Please note that all names will be kept separate from the data, so that performance on the
instruments will remain confidential.

Participation in the study is completely voluntary. Potential participants may choose not to
participate in the study after reviewing the forms may stop their participation at any time during
the testing session.
Those who choose to participate will complete a short questionnaire focusing on self and family,
a computerized attention test, 2 tasks that assess speed of thinking, 2 tasks that look at memory
and thinking. Once the information is completed, participants will receive a $25 gift card.
Participants will also be given money if needed to cover their trip to and fiom the hospital, if
needed.
Participation in the study is completely voluntary. Potential participants may choose not to
participate in the study after reviewing the forms may stop their participation at any time during
the testing session.
Please be assured that all participants' anonymity will be protected in various ways. Although the
pages are coded by number in order according to the scheduled appointment, no identifying
information will be requested in the study. No part of the study requires that participants provide
their names or other information that will reveal their identity. Results of the study will be
reported based on group data only.
Please be assured that all participants' anonymity will be protected in various ways. Although the
pages are coded by number in order according to the scheduled appointment, no identifying
information will be requested in the study. No part of the study requires that participants provide
their names or other information that will reveal their identity. Results of the study will be
reported based on group data only.
All protocols will be stored in a locked cabinet maintained at the medical center by Ms.
Tagliareni. Data fiom these forms and the computer responses will be transferred to a computer
database, available only by the researchers. Further, the completed pages will be shredded as will
the computer scores be erased, once the database has been created and reviewed for accuracy. No
one outside the researchers will have access to these questionnaires.

If you have any questions, you may contact the primary researcher, Laura J. Tagliareni, M.A. at
(201) 996-5332 or tadiala@shu.edu.
Thankyou for your consideration.
Sincerely,

Laura J. Tagliareni, M.A.
Solicitation Letter for Healthy Participants
I am inviting you to participate in a research study that will examine children and adolescents
across several areas of functioning. You have been asked to take part in this study because you
are an individual without any major health problems.
The study is being conducted by Laura J. Tagliareni, M.A., a doctoral student in the Counseling
Psychology Program at Seton Hall University, South Orange, New Jersey and an employee at the
medical center where the study is taking place.
The purpose of the study is: (1) to see how quickly children are able to complete tasks and how
they remember new information (2) to see if older adolescents complete tasks slower than their
younger peers (3) to see if older adolescents have more difficulty remembering new information
than their younger peers (4) to see if some children and adolescents tire more quickly at tests than
others. Estimated time of participation is 1 hour.
Individuals 18 years and older or parents interested in having their child participate in this study
should contact Laura Tagliareni at 201 -996-5332 to schedule an appointment to complete the
research battery at the medical center. Once the appointment is scheduled, Ms. Tagliareni will
meet with you to complete a form that you will sign only if you decide that you want to do the
study. A research assistant will then begin the study with you.
Those who choose to participate will complete a short questionnaire focusing on self and family,
a computerized attention test, 2 tasks that assess speed of thinking, 2 tasks that look at memory
and thinking. Once the information is completed, participants will receive a $25 gift card.

Participants will also be given money if needed to cover their trip to and from the hospital, if
needed.
Participation in the study is completely voluntary. Potential participants may choose not to
participate in the study after reviewing the forms may stop their participation at any time during
the testing session.
Please be assured that all participants' anonymity will be protected ir~various ways. Although the
pages are coded by number in order according to the scheduled appointment, no identifying
information will be requested in the study. No part of the study requires that participants provide
their names or other information that will reveal their identity. Results of the study will be
reported based on group data only.
All protocols will be stored in a locked cabinet maintained at the medical center by Ms.
Tagliareni. Data from these forms and the computer responses will be transferred to a computer
database, available only by the researchers. Further, the completed pages will be shredded as will
the computer scores be erased, once the database has been created and reviewed for accuracy. No
one outside the researchers will have access to these questionnaires.
If you have any questions, you may contact the primary researcher, Laura J. Tagliareni, M.A. at
(201) 996-5332 or taeliala@shu.edu. Thank you for your consideration.
Sincerely,

Laura J. Tagliareni, M.A.

Appendix B

Consent and Assent Forms

ORAL ASSENT BY MINOR SUBJECT (UNDER 12 YEARS OF AGE)
(to be read to child)
Hello, (minor's name). My name is (researcher). I'm from the Department of
Counseling Psychology at Seton Hall University. My job is to ask you some
questions and give you a computer test. I'm here to give you some of these test
questions. Your (parentlguardian) has given me permission to talk to you. All of
the questions and computer test will take about 1 hour.
You can decide if you want to meet with me or not. You may decide to stop at
any time. Whatever you decide to do is okay, and you and your family will not get
into any trouble if you decide to stop or not meet with me.
Everything that we do today is confidential. That means that no one will know
who took these tests today.
You will be given $25 at the end of our session as a thank you for your time.
Do you have any questions for me?
If it okay with you to begin, I will need you to sign the paper below. I can read the
form to you if you need help.
You are being asked to agree to participate in this research study. You have the
right to find out what is involved for you if you do the study, and to tell your
parent(s) whether you do or do not want to do the study.
Your parents will also be asked to give permission for you to do the study.
Laura Tagliareni, M.A. (or her researcher) and your parent(s) have explained to
you the steps that are involved, and you understand them.
Laura Tagliareni, M.A. (or her researcher) and your parent(s) have also
explained to you what you will do today in the study.

You have asked any questions you have, and all your questions have been
answered.
You understand everything that has been told to you.
Check one:
I agree to participate in this study.
I do not agree to participate in this study.
Child subjects and their parentdlegal guardians will be given a copy of the
signed, dated Oral Assent Procedure or Script before their participation begins.

Child's Name

Child's Age

ParentlGuardian

Date

Researcher

Date

*Parents/Guardians must also read and sign the informed consent before d d d
participates.

ASSENT BY MINOR SUBJECT TWELVE YEARS OF AGE OR OLDER

You are being asked to agree to participate in this research study. You have the
right to find out what is involved for you if you participate, and to tell your parent
or guardian@) whether you do or do not want to participate. Your parents will
also be asked to give permission for you to participate in this study.
The study is being done by Laura Tagliareni, M.A. She is from the Department of
Counseling Psychology at Seton Hall University and works at this hospital.
The purpose of the study is to see how children learn.
Ms. Tagliareni and her researchers will ask you some questions and give you a
computer test. All of the questions and computer test will take about 1 hour.
You can decide if you want to meet with Ms. Tagliareni and her research
assistants or not. You may decide to stop at any time. Whatever you decide to do
is okay, and you and your family will not get into any trouble if you decide to stop
or if you do not want to begin the study.
Everything that we do today is confidential. That means that no one will know
who took these tests today.
You will be given $25 at the end of our session as a thank you for your time.
If you have any questions about today, please ask Ms. Tagliareni.
If you are okay to begin, you will sign the paper below.
Laura Tagliareni, M.A. (or her researcher) and your parent@) have explained to
you the procedures that are involved, and you understand them.
Laura J. Tagliareni, M.A. (or her research assistant) and your parent(s) have
explained to you the procedures that are involved, and you understand them.
You have asked any questions you have, and all your questions have been
answered.
You understand everything that has been told to you.

Check one:
I agree to participate in this study.

-

I do

agree to participate in this study.

Child subjects and their parentdlegal guardians will be given a copy of the
signed, countersigned and dated Assent Form before their participation begins

Child's Name

Child's Signature

Child's Age

Signature

Date

ParenVLegal Guardian

Date

Researcher

Date

*Parents/Guardians must also read and sign the informed consent before child
participates.

Informed Consent for Parents
You are invited to permit your child to participate in a research study comparing children and
adolescents with and without Sickle Cell across several areas.

Researcher's Afiliation
This study is being conducted by Laura J. Tagliareni, M.A., a doctoral student in the Counseling
Psychology Program at Seton Hall University, South Orange, New Jersey and an employee at the
medical center where the study is taking place.

P u p s e and Duration of Study
The purpose of the study is: (1) to see how quickly children are able to complete tasks and how
they remember new information (2) to see if older adolescents complete tasks slower than their
younger peers (3) to see if older adolescents have more difficulty remembering new information
than their younger peers (4) to see if some children and adolescents tire more quickly at tests than
others.
Estimated time of participation is 1 hour.

Procedures and Instruments
Participants will meet with the primary researcher to complete an informed consent or assent. A
research assistant will then begin the study. Those who choose to participate will complete a short
questionnaire focusing on self and family, a computerized attention test, 2 tasks that assess speed
of thinking, and 2 tasks that look at memory and thinking.
Once the information is completed, participants will receive a $25 gift card. Participants will also
be given money to cover the cost of their trip to and fkom the hospital if needed.

VoluntaiyNature of the Study
Participation in the study is completely voluntary. M e r reviewing the informed consent
participants may stop participating at any time during the testing session.

Anonymity
Please be assured that all participants' anonymity will be protected in various ways. Although
pages are coded by number in order according to the scheduled appointment, no identifying
information will be requested in the study. No part of the study requires that participants provide
their names or other information that will reveal their identity. Results of the study will be
reported based on group data only.
Confdentiality of Data
Please note that all names will be kept separate from the data, so that performance on the
instruments will remain confidential.
All protocols will be stored in a locked cabinet maintained at Hackensack University Medical
Center by Ms. Tagliareni. Data from these forms and the computer responses will be transferred
to a computer database which will be stored electronically on a USB memory key, accessible only
by the researchers. Further, the completed pages will be shredded as will the computer scores be
erased, once the database has been created and reviewed for accuracy. No one outside the
researchers will have access to these questionnaires.
Rish and Discomforts
There are no anticipated risks or discomforts.
Benefits
No direct benefits to subjects are expected from this research. The knowledge gained from the
study will likely help understand specific aspects of learning. The fmdings may help
psychologists to better understand how children and adolescents with Sickle Cell Disease learn,
which will help in educational and academic planning for student accommodations and
interventions.
All subjects will receive a copy of the signed and dated Informed Consent form prior to
participation in the study.

Contact Information

If you have any questions, you may contact the primary researcher, Laura J. Tagliareni, M.A. at

(XXX)XXX-XXXX at XXXXXXXXX Medical Center or her faculty advisor, Laura Palmer,
Ph.D., Chair of the Counseling Psychology Ph.D. program at Seton Hall University. This study
was approved by the Institutional Review Board at Seton Hall University. Mary Ruzicka, Ph.D.,
the Director of the IRB, may be contacted by phone at 973-3 13-6314. The principal investigator,
faculty advisor, andlor IRB committee may be contacted at any time to answer questions
regarding the research.
Thankyou for your consideration.

Participant or ParentIGuardian

Date

Researcher

Date

Appendix C

Demographic Form

Please provide the following information about yourself, which will help us to better understand
the results of this study. This information is strictly confidential, and will only be reported in
group format.
1.Birthdate:

(monthdayb ear)

2. Age:
3. Gender:
4. Current grade in school. If college, please indicate year.

6 . Parents' education:
Some high school
High school graduate
Some college
2 year college
Technical school
4 year college
Post graduate
7. Approximate annual household income:

Less than $10,000
$10,000 to $19,999
$20,000 to $29,999
$30,000 to $39,999
$40,000 to $49,000
$50,000 to $59,000
$60,000 to $69,000
$70,000 to $79,000
$80,000 to $89,000
$90,000 to $99,000
Greater than $100,000
8.. Please list any prenatal problems:
9. Please list any problems at birth:

10. Please list all medical conditions/diagnoses:
If Sickle Cell Disease, please indicate age of diagnosis:

11. Please list any form of documented disability, including Learning Disabilities.

12. Please list all current medications:
13. Number of hospitalizations related to SCD in the past year
Not applicable
14. Number of hospitalizations related to SCD throughout your lifetime
Not applicable

No

*15. Have you ever experienced any type of stroke? Please check. Yes

If history of stroke, you are not eligible for this study.

* 16. Have you ever received a bone marrow transplant?
If Yes, please inform the researcher as you are not eligible in the current study.
17. Are you currently experiencing any pain? If so, please circle the extent of your cwent Pain:
0

No pain

1

2

3

4

5

6

7

Moderate Pain

8

9

10

Severe Pain

* 18. Is your pain greater than 5? Yes or No

* If you responded yes to these questions, please notify the researcher immediately, as
you are not eligible for the current study.
Thankyou for your participation.

